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ABSTRACT 
Associations between the Adult ADHD Self-Report Rating Scale (ASRS) 
and the Test of Differential Inhibition and Attention (TDIA) 
A. Benton Darling, M.A.
Attention-Deficit/Hyperactivity Disorder (ADHD) ranks among the most common mental health 
disorders in adults (APA, 2013). ADHD assessment is complicated by heterogenous symptoms, 
gender and age differences in diagnosis, variability in symptom manifestation across the lifespan, 
and comorbidity with other psychiatric disorders and medical conditions (Asherson, 2016; 
Willcut, 2012; Williamson & Johnston, 2015). The stop-signal task (SST) identifies ADHD 
clinical groups in children and adults (Lifffijt et al., 2005), yet it remains unclear whether SST 
performance reflects general deficits in attention (Alderson et al., 2007) or a selective deficit in 
motor response inhibition (Aron & Poldrack, 2005). Studies of SST often involve lower 
cognitive complexity without the additional inhibitory load produced by interference control 
(Uno et al., 2006). Currently, there is no research on SST with interference control in the adult 
population. The aim of this study was to assess the diagnostic utility of response inhibition 
metrics in the adult population on tasks with greater central processing demands. Forty-nine 
adults completed the Adult ADHD Self-Report Scale – V1.1 Symptoms Checklist and the Test 
of Differential Inhibition and Attention (TDIA). Results from hierarchical multiple linear 
regression analyses showed that TDIA metrics associated with motor response inhibition 
significantly predicted self-reported symptoms of inattention, hyperactivity-impulsivity, and 
combined ADHD, over and above metrics representing general attention. This study supports the 
clinical utility of SST with interference control in identifying ADHD in adults. Furthermore, the 
results support a conceptual model of ADHD wherein response control deficits are primary to the 
executive dysfunction associated with the disorder. Possible explanations for these results, 
limitations of the study, and future directions are explored. 
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CHAPTER 1: INTRODUCTION AND REVIEW OF SELECTED LITERATURE 
Attention-Deficit/Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder 
characterized by developmentally inappropriate symptoms of inattention, hyperactivity and 
impulsivity. Symptoms of ADHD are pervasive across multiple settings with functional and 
developmental impairment in academic, occupational, and social domains (American Psychiatric 
Association [APA], 2013). ADHD symptoms may present in childhood, adolescence, or 
adulthood and early impairment may persist across the lifespan (APA, 2013; Biederman et al., 
2012). 
ADHD was once considered to be solely a childhood disorder with symptoms that 
attenuated prior to adulthood (Efron, 2015). Research has since clearly demonstrated that ADHD 
symptoms may persist beyond childhood (Biederman, Petty, Evans, Small, & Faraone, 2010; 
Guelzow, Loya, & Hinshaw, 2017; Langley et al., 2010). Moreover, there is increasing evidence 
for symptom onset during adolescence and adulthood (i.e., after age 12 years), thereby 
challenging the notion that ADHD is a childhood disorder (Moffitt et al., 2015). Indeed, ADHD 
now ranks among the most common mental health disorders in adults (APA, 2013) with 
clinically significant impairment in social, academic, vocational, and neuropsychological 
functioning (Klein et al., 2012). ADHD was also once considered to be a disorder of emotional 
and behavioral immaturity among prepubescent children (APA, 1968). This antiquated model 
has since been supplanted by a modern conceptualization based on cognitive and executive 
dysfunction (Barkley, 1997; Douglas, 1972). 
As our understanding of the etiology and pathology of ADHD continues to evolve, there 
is increasing need for diagnostic tools that reflect these scientific advancements. ADHD 
assessment is complicated by a variety of factors including heterogeneity in symptoms, gender 
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and age differences in rates of diagnosis, variability in symptom manifestation across the 
lifespan, and high comorbidity with other psychiatric disorders and medical conditions 
(Asherson, 2016; Willcut, 2012; Williamson & Johnston, 2015). Additionally, ADHD is 
associated with deficits in academic, social, occupational, and emotional functioning, making it 
difficult to differentiate ADHD from other psychiatric disorders (Bruner, Kuryluk, & Whitton, 
2015; Klein et al., 2012; Prevatt & Young, 2014; Skirrow & Asherson, 2013).  
Identifying ADHD in adults is a particularly challenging clinical endeavor, especially 
with individuals whose symptoms present during adolescence or adulthood (Agnew-Blais et al., 
2016; Caye et al., 2016; Moffitt et al., 2015). Because current diagnostic criteria require a history 
of childhood onset and impairment (APA, 2013), assessment methods with adult patients often 
involve retrospective self- and collateral-report of symptoms, which are known to have limited 
validity and reliability (Sibley et al., 2012). Furthermore, there may be no childhood impairment 
for individuals whose symptoms first present in adulthood (Moffitt et al., 2015), thus our current 
diagnostic criteria may be too restrictive to accurately capture the nature of ADHD in some 
cases. Potential secondary gains such as access to ADHD medication and eligibility for social 
and academic services for individuals diagnosed with ADHD add complexity to the assessment 
process (Leppma, Long, Smith, & Lassiter, 2017). Finally, symptom manifestation may vary in 
adulthood as a function of self-selected environments, thereby creating context-specific 
impairment (Lasky et al., 2016). Individuals may pursue activities and environments that 
minimize their perceptions of impairment, thereby masking more global deficits associated with 
ADHD (Mordre, Groholt, Sandstad, & Myhre, 2012).  
Because of these challenges, it behooves diagnosticians to develop instruments that can 
validly and reliably identify ADHD while differentiating affected individuals from other clinical 
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and non-clinical populations. The stop-signal task (SST) is useful in identifying ADHD and non-
ADHD groups (Alderson, Rapport, & Kofler, 2007; Aron, Dowson, Sahakian, & Robbins, 2003; 
Lijffijt, Kenemans, Verbaten, & van Engeland, 2005; Oosterlaan, Logan, & Sergeant, 1998; 
Wodushek & Neumann, 2003), and yet the reason for its utility remains an area of scholarly 
debate. A segment of the cognitive psychology community points to inefficient processing due to 
generalized attention deficit as the predominate feature of individuals with ADHD compared to 
controls (Alderson et al., 2007; Castellanos & Tannock, 2002; Epstein et al., 2010; Lifffijt et al., 
2005; Oosterlaan et al., 1998). Conversely, many researchers have highlighted cognitive control 
deficits associated with motor response inhibition as a core feature of ADHD, with stop-signal 
inhibition being proposed as a key endophenotype (Aron et al., 2003; Aron & Poldrack, 2005; 
Berger & Cassuto, 2014; Hart et al., 2014; Kofler et al., 2013; McAuley, Crosbie, Charach, & 
Schachar, 2013; Schachar et al., 2005; Wodushek & Neumann, 2003). The emphasis on a 
general deficit in cognitive control versus a selective deficit in response inhibition varies across 
studies of SST, the majority of which involve tasks of lower cognitive complexity without the 
additional inhibitory load introduced by interference control (Uno et al., 2006; van Velzen, 
Vriend, de Witt, & van den Heuvel, 2014). Absent from the SST literature is assessment of the 
diagnostic utility of response inhibition metrics in the adult population on tasks with greater 
central processing demands produced by interference control.   
In this study, I take an initial step toward clarifying the clinical utility of response 
inhibition metrics in the assessment of ADHD in adulthood. I preliminarily assessed the clinical 
utility of a newly developed measure of attentional processing and response control by 
examining performances in a sample of clinical and non-clinical adults (i.e., 18 years of age or 
older). The purpose of the study is to advance the development of a new diagnostic tool while 
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evidencing response inhibition deficits in individuals with ADHD based on stopping latencies in 
the stop-signal paradigm. 
Review of Selected Literature 
Prevalence 
ADHD is generally considered a disorder of childhood with prepubescent onset (APA, 2013). A 
report by the National Institute of Mental Health (NIMH; 2017) showed that the median age of 
symptom onset for children was six years. ADHD ranks among the most prevalent mental health 
disorders in children and adolescents in the United States (NIMH, 2010) and is associated with 
national economic costs estimated between $143 and $676 billion (Doshi et al., 2012). The 
average cost of raising a child with ADHD is estimated at $15,000 (before treatment expenses), 
more than five times the average amount spent by neurotypical families (Zhao et al., 2019). In 
the study, parents and caregivers of participants with ADHD often experienced indirect costs 
related to inconsistent employment and lower work efficiency. 
Assessments of national trends revealed increases in diagnoses by 66% from 2000 to 
2010 (Garfield et al., 2012), by 42% from 2003 to 2011 (NIMH, 2017), and by 31% between 
2010 and 2017 (Blue Cross Blue Shield Association, 2019). It is estimated that the current 
worldwide prevalence of ADHD in childhood ranges from 5% (Asherson, 2016) to 7.2% 
(Thomas, Sanders, Doust, Beller, & Glasziou, 2015) and from 2.5–4.4% in adulthood (APA, 
2013; NIMH, 2017), ranking it among the most common psychiatric conditions among children 
(NIMH, 2010) and adults (APA, 2013).   
Subtypes and Symptoms 
ADHD is heterogeneous in clinical presentation as evidenced by three subsyndromal types: 
predominantly inattentive, predominantly hyperactive/impulsive, and combined presentation 
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(APA, 2013). The predominantly inattentive presentation is characterized by difficulty with 
sustained attention, task completion, and organization, as well as forgetfulness and distractibility. 
The predominantly hyperactive/impulsive type is marked by excessive motor activity or talking, 
action without forethought, restlessness, difficulty with turn-taking, and interruption of or 
intrusion on others. The combined designation is reserved for individuals who exhibit symptoms 
of both inattention and hyperactivity/impulsivity. Data drawn from meta-analytic studies show 
that the predominantly inattentive presentation is most common in the general population; 
however, individuals with the combined presentation are most likely to be referred for clinical 
services (Willcutt, 2012).  
Gender Differences 
Males are diagnosed with ADHD at a higher rate than females for all disorder subtypes 
(Willcut, 2012). Estimates range from 3-4:1 (Magnin & Maurs, 2017) to 9:1 (Bruchmuller, 
Margaf, & Schneider, 2012) in the clinical population, including 10:1 among children, 
specifically (Williamson & Johnston, 2015). Scholars have attributed this discrepancy to social 
processes such as methodological inconsistency (Williamson & Johnston, 2015) and systematic 
referral bias related to social expectations for behavior in boys and girls (Biederman et al., 2005).  
In one study, a sample of 1,000 mental health professionals read male and female versions of an 
otherwise identical case vignette and were asked to render or withhold a diagnosis. The male 
version resulted in a diagnosis of ADHD in about twice the number of cases compared to the 
female vignette (Bruchmuller et al., 2012). The authors posited that a representative heuristic led 
participants to view the male subjects as more prototypical of ADHD children. Other scholars 
have disagreed with this conclusion, suggesting that the discrepancy is due to genuine etiological 
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differences in genetic and cognitive liabilities that persist after controlling for selection bias 
(Arnett, Pennington, Willcutt, DeFries, & Olson, 2015).  
Age Differences 
Age differences may also be emblematic of subjectivity in diagnosis. Elder (2010) 
demonstrated that ADHD diagnoses were not based solely on underlying neurological 
conditions; instead, rates of diagnosis varied systematically depending on children’s ages relative 
to eligibility cutoffs for admittance to kindergarten in their states. Elder (2010) found that the 
youngest children were more than twice as likely to be diagnosed with ADHD compared to the 
oldest children in each grade. Younger children were also more than twice as likely to be treated 
using psychostimulant medication. These results suggest that the relative immaturity of younger 
schoolchildren may lead to disproportionately higher rates of ADHD diagnoses and subsequent 
pharmacological intervention.  
Evans, Morrill, and Parente (2010) replicated Elder’s (2010) findings using data collected 
from 1996 through 2006 by three national health organizations. Their results indicated that 
children who were older for their grade were less frequently diagnosed with and treated for 
ADHD compared to younger children. Both Elder (2010) and Evans et al. (2010) attributed their 
results, in part, to differences in maturity levels between younger and older children. Data 
collected from 2007 through 2015 showed similar trends, with significantly higher rates of 
diagnosis and treatment of ADHD among children born in August than among children born in 
September in U.S. states with a September 1 cutoff date for kindergarten admission (Layton, 
Barnett, Hicks, & Jena, 2018). 
Elder and Lubotsky (2009) suggested that younger children are more likely to exhibit 
emotional, educational, and behavioral deficits that are characteristic of ADHD endophenotypes 
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compared to older children in the same grade. APA (2013) noted that symptom identification in 
young children is complicated by high variability in normative behavior. Elder and Lubotsky 
(2009) added that developmental discrepancies may contribute to over-diagnosis of ADHD 
among young children whose symptoms are conflated by relative immaturity in comparison with 
same-grade peers. Meanwhile, older children may be underdiagnosed because their symptoms 
may be less obvious amid their younger, possibly less mature classmates. Elder and Lubotsky 
(2009) concluded that diagnosticians must consider symptom profiles relative to same-age rather 
than same-grade peers. 
Etiology and Risk Factors 
Presently there is no known single etiology for ADHD (Magnin & Maurs, 2017), though 
biological and environmental determinants have been implicated. Twin studies suggest that 
genetic heritability is between 60% and 90% (Faraone & Mick, 2010; Spencer, Biederman, 
Wilens, & Faraone, 2002; Waldman & Gizer, 2006), with a mean heritability estimated at 75% 
worldwide (Beiderman & Faraone, 2005; Faraone et al., 2005). A recent genome-wide 
association meta-analysis of 20,183 individuals diagnosed with ADHD revealed 12 genomic 
regions where people with ADHD differed from controls (Demontis et al., 2019). The 
researchers suggested that this genetic profile contributes about 22% of the risk of developing 
ADHD. 
Contributions from social or environmental factors are also implicated, with estimates 
ranging from 10% to 40% (Waldman & Gizer, 2006). For example, the basal ganglia are linked 
to ADHD for their role in motor response inhibition (Guo, Schmitz, Mur, Ferreir, & Anderson, 
2018; Shaw et al., 2014). The basal ganglia are a collection of subcortical structures in the 
telencephalon that includes the caudate nucleus, the putamen, and the globus pallidus. These 
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structures collectively facilitate or inhibit movement through interaction with the motor cortex. 
The basal ganglia are known to be particularly vulnerable to hypoxia (Froehlich et al., 2011). 
Additionally, early exposure to technologies (e.g., television) is associated with deficits in 
attentional functioning among children (Christakis, Zimmerman, DiGiuseppe, & McCarty, 2004; 
Tamama et al., 2019). Thus, the combination of biological and environmental determinants is 
cause for scholarly consensus that the etiology of ADHD is polygenetic and multifactorial 
(Magnin & Maurs, 2017; van Ewijk & Oosterlaan, 2015; Waldman & Gizer, 2006). 
Pathophysiology 
The prefrontal cortex (PFC) has consistently been the predominant focus in ADHD 
research given its association with executive functions (Arnsten, 2009). The PFC is critical in 
regulating and sustaining attention, screening distractions, inhibiting emotional and behavioral 
impulses, planning, organizing, and facilitating working memory (Arnsten, 2009; Spencer, 
Biederman, & Mick, 2007). Specific regions within the PFC are linked to particular executive 
functions. The dorsolateral PFC is associated with organization, planning, working memory, and 
attention (Bush, Valera, & Seidman, 2005). The inferior frontal gyrus of the ventrolateral PFC is 
associated with response inhibition as damage to this region was shown to elicit delays in 
response suppression on measures of attention and response control (Aron, Fletcher, Bullmore, 
Sahakian, & Robbins, 2003). Dysfunction in the orbitofrontal cortex is also indicated in ADHD 
research for its association with behavioral inhibition and impulse control (Seidman, Valera, & 
Makris, 2005). 
PFC functioning is contingent on the concentration of two primary catecholamines, 
dopamine (DA) and norepinephrine (NE), and small changes in the levels of these 
neurotransmitters have immense effects on executive functioning (Arnsten, 2009). The dopamine 
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hypothesis of ADHD suggests that deficits in tonic DA in the synaptic cleft are responsible for 
ADHD symptoms (Levy, 1991). Because the PFC is especially rich in DA (Spencer et al., 2007), 
dysfunction of the DA system in the nigrostriatal, mesolimbic, and mesocortical pathways is 
believed to account, at least partially, for PFC underactivity that underlies ADHD (Genro, 
Kieling, Rohde, & Hutz, 2010). These pathways connect the PFC to midbrain structures 
including the hippocampus, amygdala, substantia nigra, ventral tegmental area, striatum, and 
nucleus accumbens (Meyer & Quenzer, 2013). NE at high levels is also associated with PFC 
dysfunction. Stimulation of NE receptors enhances and prolongs the functioning of neural 
connections responsible for attention, behavior, and emotion regulation. Blocking NE receptors 
is associated with hyperactivity and impulsivity (Arnsten, 2009; Arnsten & Li, 2005). 
Associations between DA, NE, and ADHD have led to the development of 
pharmacotherapies that specifically target DA and NE systems in the PFC (Genro et al., 2010). 
Two common psychostimulants, methylphenidate and amphetamine, enhance neurotransmission 
of DA and NE by inhibiting reuptake of DA and NE through inhibition of dopamine transporter 
proteins (DAT) and norepinephrine transporters proteins (NET), respectively. Amphetamine 
exerts an additional effect by stimulating the release of DA and NE at the synapse (Pliszka, 
2005). When uninhibited, DAT and NET function to inactivate DA and NE through reuptake by 
moving the neurotransmitters from the synaptic cleft into nerve terminals. By inhibiting the 
membrane transporter proteins responsible for reuptake, synaptic neurotransmitter levels 
increase. Once amphetamine enters the nerve terminal, it stimulates endogenous DA release into 
the extracellular fluid, resulting in an increase in synaptic DA levels (Meyer & Quenzer, 2013). 
The etiological role of candidate genes within these neurotransmitter systems has been 
examined in molecular genetics and functional imaging studies of ADHD (Arnsten, 2009; Genro 
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et al., 2010). Genes within the dopaminergic pathway are robustly implicated as primary 
contributors to the etiology and pathophysiology of ADHD due to their important role in 
regulating attention (Ptacek, Kuzelova, & Stefano, 2011). These include the dopamine 
transporter gene (DAT1; chromosomal location 5p15.33) and receptor genes (DRD3, DRD4, and 
DRD5; chromosomal location 3q13.31, 11p15.5, and 4p16.1, respectively) (Gizer, Ficks, & 
Waldman, 2009; Waldman & Gizer, 2006). The candidate gene most widely connected with 
disorders of attention is the 7-repeat allele of the DRD4 receptor gene (Spencer et al., 2002). 
The Attentional System 
In their seminal article, Posner and Petersen (1990) identified three separable, yet 
integrated networks within the attentional system of the human brain: alerting, orienting, and 
executive control. Exploration of these networks has proven useful in identifying motor response 
inhibition as a prominent ADHD endophenotype (Hart et al., 2014; McAuley et al., 2013).  
Peterson and Posner (2012) later updated this model considering 20 years of subsequent 
cognitive neuroscience research using brain imaging technology. The following is an overview 
of their updated model of the attentional system of the human brain. 
First, the alerting network is involved in shifting between states of tonic and phasic 
alertness. Tonic alertness refers to an idle or “ready state” of intrinsic arousal. In contrast, phasic 
alertness refers to a rapid shift in arousal triggered by an environmental event that, like a warning 
signal, prepares the attentional system for signal detection and response execution (DeGutis & 
Van Vleet, 2010). The mediation of arousal involves the ascending reticular activating system, 
which is initiated by NE release in midbrain structures such as locus coeruleus projections and 
superior colliculus (Aston-Jones & Cohen, 2005). Activation of this system occurs in response to 
a cue that indicates an upcoming target stimulus (Peterson & Posner, 2012). 
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Second, signal detection is performed by the orienting system wherein sensory input, 
such as spatial cues, are processed. The orienting system is comprised of two sensory processing 
networks, the ventral attention network (VAN) and dorsal attention network (DAN). VAN is a 
bottom-up processing network used to orient to sensory stimuli outside of direct attention, or 
exogenous attention. Bottom-up processing refers to perceiving exogenous sensory information, 
allowing the stimulus to influence our perceptions or cognitive awareness in a data-driven 
manner. VAN is right lateralized in the temporoparietal junction and the ventral frontal cortex.  
Conversely, DAN uses top-down visuospatial processing to orient to expected presentations of 
stimuli based on a given task or event. Top-down processing involves the use of background or 
contextual knowledge to inform our perception of a stimulus. DAN involves exogenous and 
endogenous attention and is comprised of the frontal eye fields and the intraparietal 
sulcus/superior parietal lobe (Davidson & Marrocco, 2000). 
Finally, the executive control system involves two control networks, the frontoparietal 
network (FPN) and cingulo-opercular network (CO) (Dosenbach, Fair, Cohen, Schlaggar, & 
Petersen, 2008). The FPN includes the dorsal frontal cortex, dorsolateral prefrontal cortex, 
inferior parietal lobule, and inferior parietal sulcus. It is associated with cognitive flexibility 
required to switch between cognitive tasks (Rossi, Bichot, Desimone, & Ungerleider, 2007). The 
CO is comprised of the anterior prefrontal cortex, anterior insula/operculum, dorsal anterior 
cingulate cortex, and thalamus. It is associated with set maintenance across task trials 
(Dosenbach et al., 2008). 
Our efforts to understand the characteristics of ADHD are inextricably linked to the work 
of Posner and Petersen (1990). Identification of the networks within the human attentional 
system has resulted in advanced understanding of the neural components involved in motor 
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response inhibition. The right and left frontal gyri have been identified as key structures in 
successful inhibitory control (Aron et al., 2003; Swick, Ashley, & Turken, 2008). Functional 
connectivity research by Dambacher et al. (2013) suggests that specific response inhibition 
networks may be activated in a task-dependent manner. Their analysis revealed that tasks 
involving action restraint resulted in activation of the right superior frontal gyrus, left middle 
frontal gyrus, and the bilateral anterior cingulate cortex, while action cancellation tasks yielded 
activation of the right middle frontal gyrus, posterior cingulate cortex, and parietal regions.   
Cognitive flexibility, also known as task-switching or alternating attention, has also been 
predicted by activation of specific brain regions using fMRI. Pretrial neural activity in the basal 
ganglia, anterior cingulate cortex, prefrontal cortex, and posterior parietal cortex predicted 
subsequent cognitive flexibility during a task-switching procedure (Leber, Turk-Browne, & 
Chun, 2008).   
Taken together, the human attentional system involves multiple components (i.e., the 
alerting, orienting, and executive control systems), thus attention does not represent a single, 
unitary construct. Rather, it is a process in which each individual network plays a unique role in 
identifying when, where, and how the attentional system will function. Additionally, 
advancements in cognitive neuroscience research have revealed distinct neural mechanisms 
underlying the cognitive control deficits that are associated with ADHD, highlighted by 
activation of multiple structures within the cortico-striatal-thalamic-cortical loop (Castellanos, 
Sonuga-Barke, Milham, & Tannock, 2006). These advancements prompted efforts among 
scholars to develop and evaluate measures of motor response inhibition, such as SST. 
History of the Taxon 
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The current understanding of ADHD as a childhood disorder is rooted in clinical 
nomenclature from the 20th century (Efron, 2015). Labels used to describe the disorder now 
called ADHD have undergone multiple iterations, all of which emphasize childhood impairment.  
The taxonomy evolved from hyperkinetic reaction of childhood (APA, 1968), hyperactive child 
syndrome (Wood, Reimherr, Wender, & Johnson, 1976), and attention deficit disorder (APA, 
1980) to the current classification introduced by the APA in 1994 (APA, 1994).  
Hyperkinetic reaction of childhood (APA, 1968) attributed children’s symptoms to stress 
reactions to stimuli within the family environment (Mallet, Natarajan, & Hoy, 2014; McGough 
& McCracken, 2006). This attribution yielded a conceptualization of ADHD as a childhood 
disorder with hyperactivity caused by emotionally or behaviorally immature reactions to 
stressors. Impairment was therefore expected to diminish concurrent with normative maturation 
during puberty.   
Scholars soon challenged the notion that children outgrow hyperactivity with greater 
emotional or behavioral maturity. For instance, Wood et al. (1976) acknowledged that 
hyperactive child syndrome presents in childhood yet disagreed that impairment attenuates in 
adolescence. Instead, they suggested symptoms are transformed in adolescence and adulthood 
with impairment marked by greater inattention and impulsivity in addition to continued 
hyperactivity. Asherson (2016) added that emotional instability remains a core presentation for 
individuals with ADHD, though it is possibly a product of other impairments. Wood and 
colleagues (1976) posited that the emergence of inattentiveness does not necessarily supplant 
hyperactivity nor signify the conclusion of a childhood disorder. They added that other 
diagnostic labels (e.g., hysteria) may conceal what is more accurately conceptualized as 
persistent symptoms of childhood hyperkinesis in adulthood.  
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Our understanding of etiology changed most markedly with the work of Douglas (1972) 
and Barkley (1997) who shifted the conversation away from emotional and behavioral 
immaturity in the direction of executive dysfunction. First, Douglas (1972) emphasized 
attentional and impulse control deficits as core features of ADHD. Barkley (1997) later proposed 
a self-regulation model with five major executive impairments that contribute to the deficits 
associated with ADHD: response inhibition, working memory, self-regulation of emotion and 
motivation, and reconstitution. At the core of Barkley’s (1997) model was impairment in 
response inhibition that was unique to ADHD. All other impairments were secondary as their 
function was contingent on effective and efficient response inhibition. Barkley’s (1997) model 
was a catalyst for viewing ADHD as a disorder of executive functioning, which is known to play 
an important role in self-regulatory and goal-directed behavior (Pennington & Ozonoff, 1996).  
Barkley’s (1997) model postulates that the behavior of individuals with ADHD is highly 
regulated by their immediate environment compared to healthy controls.    
The APA (1980) paralleled this advancement by introducing the term, attention deficit 
disorder, to classify a profile of symptoms which emphasized deficits in executive control in 
accordance with Douglas’s (1972) and Barkley’s (1997) models. Indeed, numerous studies have 
since identified a variety of executive functioning deficits in ADHD such as behavioral 
inhibition (Alderson et al., 2007; Nigg, 2001; Van Mourik, Oosterlaan, & Sergeant, 2005), 
working memory (Martinussen, Hayden, Hogg-Johnson, & Tannock, 2005; Rapport, Chung, 
Shore, & Isaacs, 2001), strategic planning (Kofman, Larson, & Mstofsky, 2008), and sustained 
attention and vigilance (Egeland, Johansen, & Ueland, 2009). 
Subsequently, clinical research evidenced symptom onset and persistence in adolescence 
(Biederman et al., 2012), which prompted the APA to revise its diagnostic criteria in response to 
ASSOCIATIONS BETWEEN THE ASRS AND TDIA 
 
15 
burgeoning support for greater longevity of the disorder (APA, 1987). Still, APA (1987; 1994) 
included an age-of-onset criterion of seven years, signifying developmental onset. Barkley and 
Biederman (1997) contended that the arbitrary selection of seven years did not withstand 
empirical nor conceptual scrutiny either for onset of symptoms or impairment. These scholars 
articulated their rationale, noting that the criterion was “scientifically indefensible, poses 
unwarranted practical problems for the study of older adolescents and adults, and may be 
arbitrarily discriminatory” (p. 1204). Most recently, the age of onset criterion was revised from 
seven to 12 years with the publication of the Diagnostic and Statistical Manual of Mental 
Disorders – Fifth Edition (DSM-5; APA, 2013), extending the period during which symptom 
impairment may present by five years.  
Diagnostic Criteria 
The DSM-5 (APA, 2013) enumerates diagnostic criteria for ADHD consisting of 18 
symptoms of inattention, hyperactivity, and impulsivity. Diagnostic thresholds are determined by 
the severity of clinical impairment as symptoms of ADHD are continuously distributed 
throughout the population (Asherson, 2016). A diagnosis under the current system requires the 
presence of several symptoms of inattention and/or hyperactivity/impulsivity before the age of 
12 years (APA, 2013). Examples include “has difficulty remaining focused during lectures, 
conversations, or lengthy reading” and “often forgetful in daily activities [such as] running 
errands…returning calls, paying bills, keeping appointments” (APA, 2013, p. 59). The age-of-
onset criterion of 12 years exemplifies a present understanding of ADHD as a 
neurodevelopmental disorder with symptom onset in childhood. The DSM-5 states, “ADHD 
begins in childhood” (APA, 2013, p. 61); therefore, there is no recognition of ADHD onset 
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beyond age 12 years. Without a history of impairment in childhood, there can be no diagnosis of 
ADHD (Craig, 2011).   
Scholars debate the validity of the age criterion citing symptom onset versus persistence 
in adolescence and adulthood (Agnew-Blais et al., 2016; Caye et al., 2016; Moffitt et al., 2015).  
To some, ADHD is a lifelong condition (Magnin & Maurs, 2017); to others, ADHD can be a 
disorder solely of adulthood for some patients (Moffitt et al., 2015).   
ADHD in Adolescence and Adulthood 
Persistence. Although the prevailing notion for several decades was that ADHD was a 
neurodevelopmental disorder solely of childhood (Spencer et al., 2007), it is now estimated that 
about 2.5–4% of adults meet diagnostic criteria for ADHD (APA, 2013; Fayad et al., 2007), 
ranking it among the most common psychiatric conditions in adulthood (APA, 2013). The 
possibility that childhood ADHD symptoms may persist into adolescence and adulthood was first 
questioned by Wood et al. (1976) and officially recognized for the first time by the APA in 1987 
(APA, 1987).   
Research on ADHD in adults is relatively new, with greater than 75% of the literature 
published within the past 10 years (Williamson & Johnson, 2015). Though still in its infancy, a 
burgeoning literature supports the potential for symptom persistence beyond childhood 
(Biederman et al., 2010; Biederman et al., 2012; Klein et al., 2012; Langley et al., 2010). While 
ADHD is known to affect adult patients (Balint, Czobor, Komlosi, & Meszaros, 2009; Wilens et 
al., 2009), inconsistent research findings make it difficult to achieve consensus regarding 
persistence rates. One explanation for the variability is methodological and definitional 
inconsistency across studies, particularly the diagnostic criteria used in assessment (Magnin & 
Maurs, 2017; Spencer et al., 2007). For example, comparing rates of diagnosis among adults 
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using former (APA, 1994) and current (APA, 2013) criteria resulted in a 27% increase in 
prevalence estimates in one study (Matte et al., 2015) and 65% in another (Rigler et al., 2016).  
These figures may be associated with a more inclusive age-of-onset criterion of 12 years. Rigler 
et al. (2016) also noted that fewer symptoms are required for a diagnosis of ADHD under the 
current system, thereby lowering the diagnostic threshold. 
Some studies have reported relatively low persistence rates ranging from 4% (Mannuzza, 
Klein, Bessler, Malloy, & LaPadula, 1998) to 22% (Klein et al., 2012). Comparatively, a 
longitudinal study revealed that clinically significant childhood symptoms were retained in 
young adulthood in 58% of cases (Barkley, Fischer, Smallish, & Fletcher, 2004). Subsequent 
research showed that 70% of diagnosed children (mean age of 9.4 years) continued to meet full 
criteria for ADHD five years later in adolescence (Langley et al., 2010). Similar results were 
reported by Biederman et al. (2012) who observed either full or subthreshold symptom 
persistence in 77% of childhood cases at 10- to 16-year follow-up during adolescence.  
The persistence of symptoms beyond childhood occurs at comparable rates for boys and 
girls.  Results of a 10-year longitudinal study demonstrated that about 35% of diagnosed boys 
continued to meet diagnostic criteria in adulthood (Biederman et al., 2010). Likewise, a 10-year 
follow-up study of girls revealed that 44% met full criteria as adults (Guelzow et al., 2017).  
Although boys are diagnosed with ADHD at a higher rate than girls (Magnin & Maurs, 2017), 
based on these findings, both are comparably susceptible to persistent functional impairment 
throughout the lifespan. The degree of impairment has been shown to vary by gender, however, 
with males displaying a higher level of neurocognitive deficits as adults compared to females 
(Balint et al., 2009). 
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Data from meta-analytic studies suggest that an estimated 50% of adults remain impaired 
by persistent childhood symptoms that are detrimental to daily functioning, even when their 
symptoms are in partial remission or are subthreshold diagnostically (Faraone, Biederman, & 
Mick, 2006). A 16-year controlled, longitudinal study by Biederman et al. (2012) showed that 
adult ADHD is associated with greater psychosocial, educational, and neuropsychological 
impairment compared to age- and sex-matched controls. Symptom persistence has been 
associated with a greater number of childhood symptoms and lower childhood IQ (Agnew-Blais 
et al., 2016), as well as childhood symptom severity and treatment history (Caye et al., 2016). 
Despite overall variability in persistence rates, the potential for ADHD symptoms to be retained 
in adolescence and adulthood is well-established in the literature. 
Onset. Research is also increasingly supporting the possibility of symptom onset beyond 
childhood, at ages ranging from 13 to 38 years (Agnew-Blais et al., 2016; Caye et al., 2016; 
Moffitt et al., 2015). In a nationally representative four-decade longitudinal cohort study, Moffitt 
et al. (2015) found that 90% of adults with diagnosable ADHD did not experience clinically 
significant impairment in childhood; importantly, all DSM-5 (APA, 2013) criteria were met 
except for onset-age prior to 12 years. Based on this sample, Moffitt and colleagues (2015) 
questioned whether ADHD is in fact a childhood-onset neurodevelopmental disorder. Their data 
suggest that ADHD symptom onset may also occur after the age of 12 years. Another study 
found that adults with ADHD symptoms experience comparable levels of impairment, regardless 
of age-of-onset (Agnew-Blais et al., 2016). The researchers found few discernable differences 
between individuals with persistent and late-onset ADHD, suggesting that adult impairment is 
similar for individuals whose symptoms presented before or after age 12 years. This literature 
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provides initial support for continued revision, if not elimination, of the onset-age criterion of 12 
years in the DSM-5 (APA, 2013).   
Not all studies report equally high prevalence rates for adult-onset ADHD, however, nor 
do they report equal levels of impairment between childhood- and adult-onset ADHD. For 
example, in a sample of 388 adult outpatients, only 6.9% were classified as having adult-onset 
ADHD with symptoms that were less severe than patients with childhood-onset (Lopez, 
Micoulaud-Franchi, Galera, & Dauvilliers, 2017). Despite some evidence to the contrary, overall 
the literature suggests that clinically significant symptoms may not present until adolescence or 
young adulthood for some individuals. 
Course. Current and recent literature suggests a high degree of variability in symptom 
manifestation across the lifespan (Biederman, Faraone, Monuteaux, Bober, & Cadogen, 2004; 
Williamson & Johnston, 2015). Early childhood symptoms often manifest as excessive motor 
activity, such as running and climbing, yet children often experience a marked decline in motor 
hyperactivity during adolescence. Hyperactive symptoms often remit earlier in the lifespan than 
do inattentional effects, which become more prominent during adolescence and early adulthood 
(APA, 2013; Asherson, 2016; Biederman, Mick, & Faraone, 2000). Adults may still experience 
hyperactivity or impulsivity, but what previously manifested as excessive running and climbing, 
for example, may later present as fidgeting, impatience, or restlessness (Craig, 2011).  
Differences in symptom manifestation between children and adults may not be fully 
attributable to epidemiological factors. Manifestations of adult ADHD may be subjectively and 
contextually influenced by sociocultural variables such as academic or occupational activities 
that emphasize certain functional capacities more than others (Sibley, Mitchell, & Becker, 2016). 
Some adults with ADHD describe their impairment as context-specific, citing symptoms that are 
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strengths in one setting and liabilities in another (Lasky et al., 2016). Selection of environments 
that magnify attentional deficits and minimize hyperactivity or impulsivity, for example, may 
lead to an erroneous conclusion that inattention remits more slowly. It is also possible that 
hyperactive symptoms are equally present but do not produce the same level of functional 
impairment in their respective contexts due to specific environmental demands (Lasky et al., 
2016) or increased use of adaptive coping mechanisms (Jensen et al., 1997). There is therefore an 
interaction effect between individuals and their environments that contributes to variability in 
impairment across the lifespan (Lasky et al., 2016). 
Comorbidity and Deleterious Outcomes. Diagnosing ADHD is complicated by a high 
degree of overlap in functional impairment with a variety of neurodevelopmental and psychiatric 
disorders (Anastopolous et al., 2018; Asherson, 2016; Cadman et al., 2016). A four-year follow-
up study of diagnosed children found elevated risk for other mental health conditions including 
anxiety and mood disorders, deficient intellectual and academic functioning, and conduct 
problems (Biederman et al., 1996). A second longitudinal study followed diagnosed children into 
adulthood and found that hyperactive youth were at greater risk for conduct problems (e.g., 
property theft, assault) and illegal drug-related activity than community controls (Barkley et al., 
2004). Oppositional Defiant Disorder (ODD) and Conduct Disorder (CD) are often comorbid 
with ADHD, with estimates of dual diagnoses around 60% and 40%, respectively (Connor, 
Steeber, & McBurnett, 2010). Several studies have also reported increased risk of substance use 
disorders among ADHD patients (Estevez et al., 2016; Young et al., 2015) with twice the 
population rate among clinical samples (Asherson, 2016). Children with ADHD were found to 
be three times more likely to use nicotine or marijuana in their lifetime than individuals without 
ADHD (Lee, Humphreys, Flory, Liu, & Glass, 2011). Childhood ADHD has also been shown to 
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predict earlier onset and higher rates of risky sexual behavior in young adulthood (Flory, Molina, 
Pelham, Gnagy, & Smith, 2006). 
ADHD is also related to greater emotional dysregulation (Lenzi, Cortese, Harris, & Masi, 
2018; Skirrow & Asherson, 2013), feelings of loneliness (Stickley, Koyanagi, Takahashi, 
Ruchkin, & Kamio, 2017), depression (Bron et al., 2016; Michielsen et al., 2013; Simon, 
Czobor, & Bitter, 2013), and suicidality (Stickley, Koyanagi, Ruchkin, & Kamio, 2016). 
Individuals with ADHD may be at greater risk for prolonged mood dysregulation as evidenced 
by findings that ADHD is associated with increased treatment resistance to antidepressant 
medication (Chen et al., 2016).   
Higher rates of antisocial personality disorder have been reported for samples of ADHD 
patients (Biederman et al., 2004; Klein et al., 2012). Research has also associated ADHD with 
medical conditions including obesity (Nigg et al., 2016), bulimia nervosa (Ziobrowski, 
Brewerton, & Duncan, 2018) and other disordered eating behaviors (Bleck & DeBate, 2013; 
Kaisari, Dourish, & Higgs, 2017; Levin & Rawana, 2016), celiac disease (Instanes, Klungsoyr, 
Halmou, Fasmer, & Haavik, 2018), and premature death (Dalsagaard, Ostergaard, Leckman, 
Mortensen, & Pedersen, 2015; London & Landes, 2016). ADHD has been associated with 
neurodevelopmental disorders including autism spectrum disorder (Gillberg et al., 2004) and 
specific learning disorder (Sexton, Gelhorn, Bell, & Classi, 2012).   
In addition to comorbid medical and mental health concerns, individuals with ADHD 
often experience greater social, occupational, and vocational dysfunction (Spencer et al., 2002). 
ADHD is associated with a variety of poorer outcomes in academic, emotional, social, and legal 
domains among adolescents (Spencer et al., 2007). Symptoms in adulthood have been associated 
with lower socioeconomic status (Borland & Heckman, 1976), as well as greater prevalence of 
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psychological maladjustment, traffic offenses, disruptions in employment, and divorce (Murphy 
& Barkley, 1996).   
In a 33-year longitudinal assessment of clinical and functional outcomes of childhood 
ADHD, Klein et al. (2012) reported relative dysfunction among probands in educational, 
occupational, economic, and social domains compared to unaffected peers. The clinical sample 
had 2.5 fewer years of education on average with significantly lower occupational attainment and 
median annual salary, and significantly higher rates of divorce. Individuals with ADHD also 
showed higher rates of incarceration, psychiatric hospitalization, and mortality. Bruner and 
colleagues (2015) corroborated these results by finding diminished social functioning via 
impaired relationship quality in young adults with ADHD.   
Kessler et al. (2006) demonstrated that adult ADHD was associated with greater rates of 
disability on all three dimensions of basic functioning as assessed by the World Health 
Organization’s Disability Schedule: self-care, mobility, and cognition. They also noted deficits in 
instrumental functioning including days out of role, productive role functioning, and social role 
functioning. Finally, research has also indicated poorer academic performance (Prevatt & Young, 
2014) and higher prevalence of learning disorders (DuPaul, Gormley, & Laracy, 2013) among 
individuals with ADHD. 
The literature is clear that persistent childhood ADHD symptoms are associated with a 
myriad of far-reaching and deleterious outcomes. Comorbidity among ADHD and other 
psychiatric or medical conditions presents a formidable challenge to diagnosticians. For 
instruments to be effective, they must aid clinicians in differentiating ADHD from other 
disorders. Importantly, functional impairment associated with ADHD has been shown to exert 
itself independently from concurrent mental health problems. The neuropsychological (Faraone 
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et al., 2000), psychosocial, educational, occupational, and cognitive impairment (Biederman et 
al., 2012) linked to ADHD symptoms have been shown to persist after statistically controlling 
for comorbid psychiatric conditions. Comprehensive and accurate assessment is therefore critical 
for identifying ADHD in clinical presentations with high comorbidity. 
Assessment and Diagnosis of Adult ADHD 
Accurate assessment and diagnosis of ADHD in adulthood is a challenging clinical 
endeavor due to heterogeneous and ambiguous symptoms (Uno et al., 2006), variability in 
functional impairment (Spencer et al., 2007), presence of comorbid disorders (Faraone et al., 
2000), and use of instruments that were intended to diagnose ADHD in children and adolescents 
(Simon, Czobor, Balint, Meszaros, & Bitter, 2009). Scholars debate whether ADHD can be 
validly and reliably diagnosed, citing patterns of over-diagnosis and under-diagnosis in children 
and adults (Bruchmuller et al., 2012; Cuffe, Moore, & McKeown, 2005; Ginsberg, Quintero, 
Anand, Casillas, & Upadhyaya, 2014; Sibley et al., 2016; Young & Goodman, 2016). Wakefield 
(2015) claimed that there is “overwhelming evidence” that ADHD is highly over-diagnosed 
leading to a “massive false-positives problem” (p. 193). Such a trend risks pathologizing 
normative behavior, which Frances and Widiger (2012) cautioned could result in largescale 
consequences in medication side effects, stigma, and insurance problems. Elder (2010) estimated 
that between $320 and $500 million is spent annually on pharmacological treatment for 
individuals with invalid diagnoses of ADHD. 
Other scholars have contended that ADHD is not itself a distinct entity, but rather a 
constellation of symptoms from multiple disorders (Weinberg & Brumback, 1992). This position 
is supported by research that suggests that each subtype originates in distinctive brain regions 
(Stevens, Pearlson, Calhoun, & Bessette, 2018). fMRI scans revealed that children with 
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impairment in executive functions and reward management demonstrated separate brain 
abnormality through individual, functionally specialized neurobiological pathways. Mallett et al. 
(2014) argued that recent changes to the diagnostic criteria for ADHD “are supported by limited 
and, at times, contradictory validity evidence” (p. 46). These authors added that “there simply is 
not sufficient empirical evidence to have confidence that the mental health field in the United 
States has ADHD diagnosis correct” (p. 46). What these and other critics may point to is 
ambiguity in our understanding of the etiology, pathophysiology, and epidemiology of ADHD. 
Our ability to accurately assess and diagnose ADHD is limited by an incomplete, albeit evolving 
explanatory model of the disorder.  
Presently there is no single diagnostic tool that represents the “gold standard” for 
identifying ADHD. Current assessment methods involve a combination of measures including a 
structured diagnostic interview, current and retrospective self-report, collateral reports from 
multiple sources intended to verify impairment history (e.g., parent and teacher rating forms), a 
computer-based continuous performance test (CPT), and a symptom validity measure. Although 
a plethora of diagnostic instruments are currently available, there remains no clear agreement on 
the most appropriate composition of a test battery (Fuermaier, Fricke, de Vries, Tucha, & Tucha, 
2018; Huang-Pollock, Karalunas, Tam, & Moore, 2012).   
Self-Report. Self-report measures of current and past functioning are often a core feature 
in ADHD evaluations (Taylor, Deb, & Unwin, 2011). Retrospective assessment is especially 
critical with adult patients to establish or rule-out a childhood impairment history. This is 
however a difficult task as patients often serve as the primary informants regarding their 
childhood experiences. Inclusion of retrospective versus prospective data is important based on 
evidence from Moffitt and colleagues (2009) that lifetime prevalence rates of mental disorders 
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are doubled when prospective methods are used. Additionally, reliance on self-report in the form 
of retrospective recall to establish childhood symptoms is known to be inaccurate and unreliable 
(Miller, Newcorn, & Halperin, 2010; Sibley et al., 2012), and vulnerable to feigned 
symptomatology (Bryant et al., 2018). 
Accurate recall is crucial because childhood impairment is a prerequisite for an ADHD 
diagnosis in adulthood based on the current criterion set (APA, 2013). Inaccurate recall can lead 
to difficulties in determining the development and trajectory of the disorder. One longitudinal 
study with young adults highlighted low to barely moderate correspondence (r = .16 – .32) 
between retrospective and prospective self-reported measures of childhood hyperactivity (Henry, 
Moffitt, Caspi, Langley, & Silva, 1994). Based on relatively low agreement on a variety of 
psychosocial variables, the authors concluded that retrospective self-report measures in social 
science research should be used with caution. Continuing this line of inquiry, an ADHD 
diagnosis was shown to be at least 9-11 times more likely using parent-report than with self-
report at follow-up in young adulthood (Barkley, Fischer, Smallish, & Fletcher, 2002). 
Participants tended to retrospectively underreport their childhood symptoms, rendering them 
increasingly ineligible for a diagnosis. 
In contrast, Murphy and Schachar (2000) found significant positive correlations between 
adults’ self-reports of childhood symptoms and retrospective ratings of childhood symptoms 
provided by parents. With a second sample, Murphy and Schachar (2000) reported significant 
positive correlations between adult self-reports of current symptoms with ratings provided 
simultaneously by partners. Favorably, the revised age-of-onset criterion (APA, 2013) may be 
advantageous in that it minimizes error in retrospective report by reducing the necessary 
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recollection period and emphasizes middle rather than early childhood. Both may enhance 
predictive validity. 
The use of self-report measures in social science research leads to internal validity 
concerns based on potential confounding variables such as self-deceptive enhancement (Pauls & 
Crost, 2004), positive impression management (Bolino, Kacmar, Turnley, & Gilstrap, 2008), and 
social desirability (Crowne & Marlowe, 1960). Self-deceptive enhancement refers to an 
unwitting response style characterized by inflated or overly favorable self-report (Pauls & Crost, 
2004). Positive impression management refers to a method of self-presentation wherein a 
response pattern reflects intentional effort to present oneself in a favorable manner (Weiss, 
Weiss, Cain, & Manley, 2009). Social desirability refers to biased responding based on social 
norms whereby responses represent social artifacts rather than raters’ pure relationships to or 
perceptions of the variable(s) of interest (King & Bruner, 2000). Social desirability is considered 
a robust threat to the validity of self-report measures, likely to result in underreporting of 
negative experiences (Ben-Porath, 2013; Huang, Liao, & Chang, 1998). Meta-analytic data 
showed that only 31 of over 14,000 health-related research studies (i.e., 0.22%) accounted for 
social desirability response bias (van de Mortel, 2008). Under these circumstances, self-report is 
likely to be inaccurate in that impairment is underreported and presentations are overly 
favorable. 
Recall bias represents a major threat to internal validity in retrospective research using 
self-reported data (Hassan, 2006). Research has shown that self-evaluation among children and 
adults with ADHD is prone to underreporting of symptoms and impairment on performance 
related measures (Hoza, Vaughn, Waschbusch, Murray-Close, & McCabe, 2012; Knouse, 
Bagwell, Barkley, & Murphy, 2005; Kooji et al., 2008; Owens, Goldfine, Evangelista, Hoza, & 
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Kaiser, 2007; Owens & Hoza, 2003). Across these studies, self-ratings of performance were 
consistently higher than those of collateral informants. Diener and Milich (1997) point to 
positive illusory bias as an explanation for this pattern, which they described as a self-protective 
mechanism whereby children with ADHD enhance their self-view in areas of deficit to mitigate 
the impact of underperformance. Generally, a tendency to underreport symptom severity on self-
report measures may result in misdiagnosis or prohibition from appropriate services. Despite 
threats to validity associated with self-report measures, clinicians have historically used them to 
assess symptom presence, severity, and history (Harrison, Edwards, & Parker, 2007).   
Feigning Symptoms for Secondary Gain. Another threat to the validity of self-report 
measures is impression management in the opposite direction, or over-reporting symptoms. Self-
report ADHD measures have shown minimal test specificity to feigned impairment resulting in 
false positives (Fisher & Watkins, 2008; Jachimowicz & Geiselman, 2004). Symptom 
exaggeration may be especially likely in the presence of secondary gain (Bryant et al., 2018; 
Leppma et al., 2017), and especially feasible as information about ADHD symptoms and 
diagnostic procedures is readily accessible on the internet (Sollman, Ranseen, & Berry, 2010).   
One incentive for feigning ADHD symptoms is potential access to medication (Leppma 
et al., 2017), including those classified as psychostimulants (e.g., Adderall) and non-stimulants 
(e.g., Straterra). Such medications are generally regarded as a first-line therapy for adults with 
ADHD (Asherson, 2016; Cubillo & Rubia, 2010). Additionally, a diagnosed disability such as 
ADHD renders one potentially eligible for tax benefits and government funded programs, or to 
have student loan repayments waived (Harrison et al., 2007). For university students, a diagnosis 
of ADHD may result in eligibility for accessibility services and academic accommodations 
(Leppma et al., 2017).   
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Recently, there has been an increase in stimulant medication prescriptions in the U.S. 
(Sollman et al., 2010) and a 35% increase annually outside of the U.S. (Zetterqvist, Asherson, 
Halldner, Langstrom, & Larsson, 2013). In a U.S. database for outpatient physician visits, 87% 
of children and adolescents diagnosed with ADHD were treated with psychostimulants (Garfield 
et al., 2012). With a nationwide increase in stimulant medication prescriptions comes greater 
need for assessment methods that are sensitive to symptom over-reporting. Research has shown 
that 25-48% of adults may perform sub-optimally and exaggerate their symptoms on ADHD 
assessments when motivated by secondary gain (Constantinou, Bauer, Ashendorf, Fisher, & 
McCaffrey, 2005; Sullivan, May, & Galbally, 2007).  
One incentive to receive a diagnosis of ADHD is to gain access to stimulants to then 
divert the medication for profit (Schultz, Silvestri, & Correia, 2017). Diversion of medication 
was found to occur in 58.9% of university students with stimulant prescriptions (Galluci, Martin, 
& Usdan, 2015). Non-medical use of prescription stimulants has increased from 5.3% in 2008 
(DuPont, Coleman, Bucher, & Wilford, 2008) to 17% of students according to recent meta-
analytic data (Benson, Flory, Humphreys, & Lee, 2015). Individual studies have found that as 
many as 43% of undergraduates reported misusing their medication (Advokat, Guidry, & 
Martino, 2008). Students may be willing to pay more than $10 per pill (Cruz, Sumstine, Mendez, 
& Bavarian, 2017), which may explain why young adults are increasingly presenting at 
university counseling centers with ADHD symptoms (Harrison et al., 2007; Benson et al., 2015). 
As stimulant prescription misuse has been associated with a variety of poor medical and 
academic outcomes (Benotsch, Koester, Luckman, Martin, & Cejka, 2011; Egan, Reboussin, 
Blocker, Wolfson, & Sutfin, 2013; Reid et al., 2015; Westover & Halm, 2012), it is critical that 
assessment tools are sensitive to feigned ADHD symptomatology. 
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Leppma and colleagues (2017) recommended including a performance validity measure 
in ADHD assessments to detect deliberate underperformance or effort to feign or exaggerate 
symptoms. One such measure is the Non-Verbal Medical Symptom Validity Test (NVMSVT; 
Green, 2008). The NVMST was found to discriminate between test-takers with suboptimal effort 
and control groups comprised of adults with dementia and youth with fetal alcohol syndrome.  
Examinees’ performances are compared to these control groups to determine the likelihood of 
suboptimal performance. Green (2008) noted that patients with dementia almost never fail all 
four validity criteria and seldom fail even two, whereas malingerers often fail all four criteria.  
Such a measure can aid diagnosticians in detecting deliberate underperformance. 
Continuous Performance Tests. Continuous Performance Tests (CPT) are currently 
among the most frequently employed instruments in ADHD evaluations (Munkvold, Manger, & 
Lundervold, 2014; Sollman et al., 2010). CPT methodology was introduced in a study of the 
effects of brain damage on sustained attention and impulsivity (Rosvold, Mirsky, Sarason, 
Bransome, & Beck, 1956). Inferior performance by patients with brain damage was attributed to 
deficits in neuropsychological functioning, including diminished capacity for sustained attention.  
CPT was later used to assess signal detection, vigilance, and arousal among radar operators 
(Mackworth & Taylor, 1963). Results from these early studies prompted subsequent clinical 
research using CPT with psychiatric populations to measure neuropsychological impairment in 
individuals with attention deficits (Epstein et al., 2003). 
CPT is a neuropsychological instrument intended to objectively and quantitatively 
measure sustained attention and response control, also known as inhibitory motor control and 
motor response inhibition (Alderson et al., 2007). Sustained attention refers to the ability to 
maintain a state of alertness over an extended period (Huang-Pollock et al., 2012), which is a 
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capacity thought to be compromised in individuals with ADHD (Adler et al., 2017). Motor 
response inhibition is defined as the “ability to withhold a speeded motor response prior to its 
initiation or the ability to cancel a response after it has been initiated” (Wright, Lipszyc, Dupuis, 
Thayapararajah, & Schachar, 2014, p. 429). Deficits in these two processes, action restraint and 
action cancellation, respectively, were evidenced by poorer performance among ADHD children 
on such measures compared to healthy controls (Schachar et al., 2007). Response inhibition is 
also considered a reflection of aspects of impulsivity (Bari & Robbins, 2013), playing a critical 
role in supporting flexible, goal-directed behavior amid environmental changes (Verbruggen & 
Logan, 2008). 
CPT quantifies performance on measures of attention and response control based on 
patterns of omission and commission errors, respectively (Uno et al., 2006). Omission errors 
refer to missed responses, or failure to respond to target stimuli, which is traditionally considered 
to reflect inattention (Berger & Cassuto, 2014). Commission errors refer to incorrect responses to 
non-target stimuli, or failure to inhibit a response, which is believed to reflect impulsivity. CPT 
provides a more objective alternative to reliance on subjective and retrospective recall, thereby 
countering the validity concerns that are traditionally associated with self-report measures.   
Today, some of the most widely used CPTs include the Conners’ CPT – 2nd Edition (C-
CPT-II; Conners, 2000), the Tests of Variables of Attention (TOVA; Greenberg & Waldman, 
1993), and the Integrated Visual and Auditory Continuous Performance Test (IVA; Sandford & 
Turner, 1995). The C-CPT-II and the TOVA measure sustained attention and response inhibition 
in the visual domain. The C-CPT-II presents a predetermined series of stimuli, 90% of which are 
targets and 10% are non-targets. Conversely, the TOVA presents a different ratio of targets to 
non-targets between the two halves of the test (Greenberg & Waldman, 1993). The IVA 
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combines aspects of both tests into a dual stimulus model in which stimuli are presented in the 
visual and auditory domains. Examinees are presented with a pseudorandom series of auditory 
and visual targets (“1”) and non-targets (“2”). Performance is assessed based on omission and 
commission errors, response times to targets, and response accuracy. Research has shown 
adequate convergence across commonly used CPTs (r = .42; Borgaro et al., 2003) based on the 
multitrait-multimethod matrix for convergent and discriminant validation (Campbell & Fiske, 
1959).   
Clinical Utility. The use of continuous performance tests in clinical assessment of ADHD 
is well-supported in the literature. Numerous studies have shown that CPT can be useful in 
differentiating between ADHD and non-ADHD groups (Losier, McGrath, & Klein, 1996; 
Epstein et al., 2003; O’Dougherty, Neuchterlein, & Drew, 1984; Sonuga-Barke, Sergeant, Nigg, 
& Willcutt, 2008; Willcutt, Doyle, Nigg, Faraone, & Pennington, 2005). In a meta-analytic 
review of 26 studies of CPT performance, children with ADHD were found to make significantly 
more errors of omission and commission compared to controls (Losier et al., 1996). Results 
indicated that children with ADHD, on average, make about twice as many errors of omission 
and commission compared to non-ADHD children. CPT performance has also been used to 
differentiate ADHD subtypes (Marks, Himelstein, Newcorn, & Halperin, 1999).   
A study by Quinn (2003) provided support for the inclusion of the IVA in ADHD 
evaluations. The study examined three randomly assigned groups of undergraduate students: (1) 
students with valid ADHD diagnoses, (2) simulated malingerers, and (3) healthy controls. Data 
was collected using a self-report ADHD checklist and the IVA CPT. Quinn (2003) hypothesized 
that simulated malingerers could successfully feign ADHD on the self-report checklist, but that 
they would be unsuccessful on the IVA due to overcompensation and lower scores than the 
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clinical group. As hypothesized, results showed that the self-report checklist lacked specificity 
and could be successfully feigned, whereas malingerers scored significantly below students with 
ADHD on 81% of subscales. The findings supported a tendency to overcompensate among 
malingerers in attempting to feign ADHD. Quinn (2003) concluded that a self-report measure by 
itself is neither sensitive nor specific enough for clinical use. ADHD evaluations may also 
include a CPT as a supplemental diagnostic tool to improve test sensitivity and specificity.  
Not all studies report favorable results, however. In one study of 201 adults diagnosed 
with and treated for ADHD, only 51.7% of the participants were classified as having the disorder 
based on their CPT performance (Baggio et al., 2019). In a study of the original Conners’ CPT 
(Conners, 1995), researchers found no significant differences in performance between children 
referred for learning disorder and/or ADHD assessment and controls (McGee, Clark, & Symons, 
2000). The instrument was deemed to be of minimal clinical utility for differential diagnosis 
based on this sample. A subsequent study corroborated the finding that differential diagnoses 
between ADHD and learning/cognitive disorders in adults could not be determined based on 
CPT performance (Advokat, Martino, Hill, & Gouvier, 2007).   
Likewise, Tollander (2011) called into question the ability of the IVA to differentiate 
between ADHD and non-ADHD groups. The study focused specifically on the Comprehension 
subscale, which measures atypical error patterns thought to reflect random or impulsive 
responding, carelessness, and inattention. Developers of the IVA claimed that Comprehension is 
the “single most sensitive subscale in discriminating ADHD” (Sandford & Turner, 2004, p. 10). 
Based on this assertion, Tollander (2011) expected Comprehension scores to differ significantly 
between ADHD participants and controls. Instead, the subscale correctly identified participants 
in each group only at chance levels. Additionally, CPT scores have been shown to be unrelated 
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to parent and teacher ratings of ADHD symptoms among clinically referred children (Edwards et 
al., 2007). 
Another concern is the ability of CPT to reliably differentiate between ADHD and other 
disorders. Mood and anxiety disorders often result in false positives on CPT (APA, 2013), 
perhaps due to known associations between anxiety disorders and response inhibition (Quay, 
1988). Low specificity for individuals with other psychiatric conditions means that low CPT 
performance may not be specific to ADHD (Fuermaier et al., 2018), but may represent 
neuropsychological deficits associated with other psychiatric disorders.    
Epstein et al. (2003) added that relationships between CPT variables and ADHD 
symptoms have not been equivocally and consistently demonstrated. Researchers pointed to 
commission errors as an example, citing an assumed connection between commission errors and 
impulsivity based on incorrect or inappropriate responding. However, in their study, four of five 
CPT parameters were related to all three ADHD symptom domains, making it difficult to 
determine which variables map onto which symptoms. Mean reaction time was the only variable 
to be significantly related with one symptom domain (i.e., hyperactivity); however, it was 
correlated with only one of the 18 ADHD symptoms. Generally, research has not yet definitively 
demonstrated which CPT parameters measure which ADHD symptoms. More research is needed 
to advance our understanding of the ADHD endophenotype to develop instruments that address 
the limitations of existing CPT. 
Go/No-Go Methodology. CPT involves detecting and responding to visual or auditory 
target stimuli amid a continuous and rapid stream of distractors for a period of 10-30 minutes. 
Examinees are instructed to respond when presented with target stimuli and to inhibit a response 
to non-targets. Different versions of CPT have been developed.  For example, in the “X version” 
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(Ogundele, Ayyash, & Banerjee, 2011), a common CPT format, examinees are presented with a 
series of stimuli and are instructed to respond only to the single target stimulus, the letter “X.”  
All other stimuli are non-targets to be resisted. Variations of this format exist in which the 
examinee is instructed to respond to all stimuli except the letter “X.” The frequency of targets 
may vary across CPTs and/or conditions from about 90% to 10%; the former measures response 
inhibition to seldom presented non-targets and the latter measures sustained attention for 
infrequent targets.  
Generally, these CPTs are referred to as “Go/No-Go” tasks (G/NG; Donders, 1969) due 
to the need to initiate a response (Go) or inhibit a response (No-Go) depending on stimulus 
presentation. The “go” response is proposed to be initiated within the brain’s Behavioral 
Activation System, whereas the “no-go” response originates in the Behavioral Inhibition System 
(Gray, 1987). G/NG tasks are designed to measure the action restraint component of response 
control in the “no-go” condition (van Velzen et al., 2014). 
Interference Control. G/NG tasks are made more difficult by including visual or auditory 
distractors within test stimuli, thereby invoking interference control (Uno et al., 2006; van 
Velzen et al., 2014). Recall that Schachar et al. (2007) assessed performance on two primary 
components of response control: action restraint and action cancellation. A third process, 
interference control, is required when stimuli are presented alongside environmental distractors. 
Examinees must resist attending to the distractors and attend only to task-relevant stimuli, 
thereby increasing the demand for sustained attention (Shalev, Ben-Simon, Mevorach, Cohen, & 
Tsal, 2011). Research suggests that CPT with environmental distractors is useful in identifying 
ADHD among adolescents (Berger & Cassuto, 2014). The ADHD group was identified based on 
ASSOCIATIONS BETWEEN THE ASRS AND TDIA 
 
35 
a significantly greater number of omission errors compared to the non-ADHD group, which 
provides evidence for deficient sustained attention among members of the clinical sample. 
Interference control can be measured by a variety of tasks including the Flanker task 
(Eriksen & Eriksen, 1974), the Simon task (Rubia, Cubillo, Woolley, Brammer, & Smith, 2011) 
and the Stroop task (Stroop, 1935; MacLeod, 1992). The Flanker task presents a target stimulus, 
typically an arrow pointing in one direction or another. Subjects are to push a button 
corresponding to the direction of the target arrow; however, the target arrow is flanked by non-
target distractors that point either in the same direction (in congruent trials) or the opposite 
direction (in incongruent trials) as the target. Subjects therefore must ignore the flankers, or 
control the interference they present, and maintain their attention on target stimuli. 
The Simon task presents an arrow pointing left or right on either the left or right side of 
the screen. In congruent trials, the left and right pointing arrows appear on the left and right side 
of the screen, respectively. In incongruent trials, the target arrow is pointing in the opposition 
direction of its location on the screen. Subjects push a left/right button depending on whether the 
arrow points left or right while ignoring the position of the target arrow on the screen. 
The Stroop task involves naming colors that appear as written words either in the same 
color ink (in congruent trials) or different color ink (in incongruent trials). A congruent trial 
would present the word red written in red ink, whereas an incongruent trial would present the 
word blue written in red ink. Responders are asked to read aloud a set of written words that are 
either congruent or incongruent with respect to ink color. Each of these three tasks involve 
interference control in the presence of non-target distractor stimuli (van Velzen et al., 2014). 
Stop Signal Paradigm. At a higher level of inhibitory demand is a G/NG task that 
includes the stop-signal task (SST; Logan, 1981; Logan & Cowan, 1984). SST adds a layer of 
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cognitive complexity by presenting a stop-signal immediately following a target stimulus, 
typically within 50-500 milliseconds. The stop-signal is commonly presented as an auditory tone 
that indicates to subjects to withhold a pre-trained target response. Pairing a target stimulus with 
a stop-signal forces subjects to cancel an already initiated response, or to apply the “mental 
breaks,” which increases the demand for inhibitory control (Schachar et al., 2007). Whereas 
basic G/NG tasks are intended to measure action initiation in “go” conditions and action restraint 
in “no-go” conditions, SST measures an additional and more complex process in action 
cancellation. It is the task with the greatest inhibitory load because the “go” process must be 
quickly overridden by the “stop” process in response to stop-signals (Schachar et al., 2007; van 
Velzen et al., 2014).  
The G/NG task is based on a theoretical model wherein the “go” and “no-go” processes 
function independently (Logan & Cowan, 1984). Known as the race model (Logan, 1994), it 
refers to the competition between two opposing processes, the response initiation and response 
inhibition processes. Whichever process wins the “race” determines the behavioral outcome. In 
support of Logan’s (1994) model, Dambacher et al. (2013) used fMRI to show that action 
restraint and action cancellation occupy distinct neural networks. Motor response inhibition is 
therefore not a unitary construct and is instead multifaceted consisting of action restraint, action 
cancellation, and interference control (van Velzen et al., 2014). Sebastian et al. (2013) proposed 
that interference control, action restraint, and action cancellation involve early, intermediate, and 
late response inhibitory processes, respectively. Barkley (1997) had previously used alternative 
labels to describe the same three processes: (1) inhibiting interference, (2) inhibiting prepotent 
responses, and (3) stopping an ongoing response. 
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The SST paradigm quantifies inhibitory control processes using the following metrics: 
mean reaction time to targets (MRT), stop-signal delay (SSD), reaction time variability (SDRT), 
and stop-signal reaction time (SSRT) (Alderson et al., 2007). MRT measures latency of the 
response execution process. It represents the average time required to perceive target stimuli and 
execute responses across a designated number of trials. SDRT supplements MRT by providing 
the standard deviation of reaction times to targets across trials. SSD is the average time between 
presentations of the target and stop-signals (i.e., SSD = MRT – SSRT). SSRT measures latency 
of the response inhibitory process and is normally distributed (Teichert & Ferrera, 2015; 
Verbruggen & Logan, 2008). SSRT is a function of the relationship between MRT and SSD (i.e., 
SSRT = MRT – SSD) and reflects the speed of the action cancellation process. 
The SSD may use a fixed, variable, or tracking go-stop method for determining the 
frequency and timing of stop-signals (Lijffijt et al., 2005). A fixed method uses a predetermined 
interval to establish the ratio of go stimuli to stop-signals. A variable method uses an interval that 
varies as a function of MRT. The tracking method was developed to counter subjects who may 
compromise speed to enhance accuracy, or engage in a speed-accuracy trade-off, whereby MRT 
increases as subjects delay responses to targets in anticipation of a stop-signal (Logan, Schachar, 
& Tannock, 1997).  Schachar et al. (2004) provided evidence for error monitoring or “detection 
of errors and subsequent adjustment of performance” (p. 285). The results demonstrated that 
children with ADHD artificially and differentially slowed their reaction time to targets following 
unsuccessful performance compared to controls. To address this effect, some measures now 
employ a tracking algorithm for SSD in which the stop-signal delay is increased by 50ms 
following successful response inhibition and decreased by 50ms following unsuccessful response 
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inhibition. This algorithm produces a desired success rate of about 50% across all trials 
(Alderson et al., 2007). 
A meta-analysis of eight studies (n = 456) of SST provided support for MRT and SSRT 
in differentiating children with ADHD from controls (Oosterlaan et al., 1998). Regarding MRT, 
latency for responding was significantly slower for ADHD children compared to controls, 
suggesting deficits in action initiation associated with inattention. Regarding SSRT, children 
with ADHD exhibited deficits in action cancellation by taking significantly longer (i.e., 103ms, 
on average) to respond to stop signals compared to controls, indicating relatively poor response 
control. These results support the use of MRT and SSRT in differentiating children with ADHD 
from non-ADHD controls. 
A subsequent meta-analysis by Lijffijt and colleagues (2005) replicated and extended the 
work of Oosterlaan et al. (1998) by including 29 articles published in the seven years between 
studies. The review also included studies of adults with ADHD, whereas the original analysis 
examined only children. The purpose was to investigate whether ADHD is primarily 
characterized by response control deficits or impaired attention. The results corroborated 
previous findings of a significant difference in SSRT between ADHD children and adults 
compared to matched controls, suggesting deficient response control in this clinical population. 
Additionally, MRT differentiated ADHD from control groups in children, but not in adults, 
providing partial support for the use of this metric to identify young patients with ADHD. Taking 
both reviews together, MRT and SSRT were successfully used to differentiate between clinical 
and non-clinical groups among children, while SSRT was the metric that differentiated groups in 
the adult sample. 
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Among children with ADHD, Lijffijt et al. (2005) found no significant differences 
between MRT and SSRT, which the authors concluded was possibly indicative of underlying 
cognitive impairment (e.g., inattention) rather than deficits in response control. For SSRT to 
reflect deficient response control, SSRT values must be disproportionately larger compared to 
MRT or there is no way to rule-out confounding variables such as impaired attention. An 
insignificant difference between MRT and SSRT suggests possible deficits in attention based on 
MRT as well as in response control based on SSRT. However, significant variability in SDRT (a 
function of MRT) was found among children with ADHD, which provides additional evidence 
for lapses of attention based on high variability in response latency to targets. This conclusion 
was supported by Epstein et al. (2010) who demonstrated that reaction time was slower for trials 
before and after errors of omission. Insignificant differences between MRT and SSRT, and 
significant variability in SDRT both point to impaired attention as a primary characteristic of 
ADHD over and above response control deficits. 
Although no differences in MRT were observed between the adult clinical and control 
groups, SSRT was significantly different between groups. Additionally, unlike in children, 
significant differences between MRT and SSRT in adults suggested deficient response control 
independent of other potential cognitive impairment, such as inattention.   
Results from these two meta-analyses are mixed regarding the utility of each metric to 
differentiate between ADHD and control groups. It appears that the composition of the sample 
may be an important factor, as different results are reported for child and adult samples. 
Oosterlaan et al. (1998) showed that both MRT and SSRT are clinically useful with children. 
Lijffijt et al. (2005) pointed specifically to MRT as the key metric among children. Their 
analysis also provided initial support for the use of SSRT with adults to differentiate between 
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groups based on impaired response control. Considering these initial findings, it remains to be 
investigated whether ADHD is characterized primarily by deficient response control or by 
inattention, and whether this primary deficit may differ across age groups. It is also important to 
consider the extent to which impairment is attributable to cross-circuit interactions. 
A subsequent meta-analytic review replicated the Oosterlaan et al. (1998) and Lijffijt et 
al. (2005) findings of significantly slower MRT among ADHD children relative to controls 
(Alderson et al., 2007), indicating impairment in action initiation. Moreover, significant 
differences in SDRT and insignificant differences in between-group SSD (i.e., MRT – SSRT) 
both replicated the Lijffijt et al. (2005) results and further supported a potential generalized 
attention deficit based on differences in MRT rather than impairment in response control based 
on SSRT. 
Overall, these meta-analyses provide a valuable, yet preliminary contribution to our 
understanding of ADHD by highlighting deficient response control and inattention as core 
features of the disorder. The results support the use of MRT and SSRT in differentiating between 
ADHD and non-ADHD groups, especially among children. Oosterlaan et al. (1998) found 
medium combined estimated effect sizes for MRT (d=0.40) and SSRT (d=0.64) using Cohen’s 
standards (Cohen, 1988). Using Lipsey and Wilson’s (2000) procedures, Lijffijt et al. (2005) 
found a significant medium effect size using MRT (0.52) and SSRT (0.58) among children. A 
medium, almost large, effect size (0.79) was also significant for SSRT among adults. Alderson et 
al. (2007) found significant medium mean effect sizes for MRT (0.45) and SSRT (0.63) among 
children using Hedges’ standards (Hedges, 1982). The analysis of adult patients (Lijffijt et al., 
2005) found a significant effect size for SSRT, which is medium (0.79) but close to the threshold 
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for a large effect (Lipsey & Wilson, 2000). At least two additional studies have found significant 
large effect sizes for SSRT in adult samples (Aron et al., 2003; Wodushek & Neumann, 2003). 
More research is needed to corroborate and clarify whether metrics associated with 
inattention (i.e., MRT) and/or response control (i.e., SSRT) are clinically useful in evaluating 
ADHD in child and adult patients. Inattention is highlighted as a predominate deficit in studies 
involving children (Alderson et al., 2007; Lijffijt et al., 2005; Oosterlaan et al., 1998), whereas 
deficient inhibitory control has been proposed as the major feature of adult ADHD (Bekker et al., 
2005; Lijffijt et al., 2005). SSRT was significantly more prolonged than MRT among adults, 
which supports Barkley’s (1997) theoretical model in which response inhibitory deficits are 
primary in ADHD. All other impairments are proposedly secondary as their function is 
contingent on effective and efficient response inhibition. Evidence of deficient inhibitory control 
may also illuminate key neuroanatomical structures involved in ADHD based on their 
association with motor response inhibition including the basal ganglia (Guo et al., 2018; Shaw et 
al., 2014), frontal gyrus, posterior cingulate cortex, and parietal regions (Dambacher et al., 
2013). 
Support for Barkley’s (1997) model is limited based on results from these meta-analyses 
for the following reasons. First, due to significant differences in SDRT and insignificant 
differences in SSD among children, both Lijffijt et al. (2005) and Alderson et al. (2007) 
concluded that clinical and non-clinical groups may differ based on action initiation (i.e., 
inattention) rather than on action cancellation (i.e., response control). When no difference exists 
between MRT and SSRT, the between-group variability may be attributable to a general deficit 
in cognitive control rather than a selective deficit in inhibition (Verbruggen & Logan, 2008). 
Second, the meta-analyses included only studies of CPT performance in the basic G-NG format 
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without non-target distractor stimuli. There was therefore no analysis of CPT performance with 
greater cognitive processing demands. The studies merely addressed response inhibition on a 
task of lower cognitive complexity without the additional inhibitory load introduced by 
interference control (Uno et al., 2006; van Velzen et al., 2014). Third, only one of the reviews 
included an adult sample, thus the conclusions made about SSRT among adult ADHD patients 
remain limited and warrant further exploration. 
Based on these limitations and mixed results, further investigation is needed to determine 
the clinical utility of SSRT relative to MRT in differentiating between groups amid higher 
cognitive processing demands. Significant differences between SSRT and MRT under these 
conditions may provide evidence for a selective deficit in response control among individuals 
with ADHD (Verbruggen & Logan, 2008). Moreover, this finding would provide contrary 
evidence for the conclusions of Lijffijt et al. (2005) and Alderson et al. (2007) that periodic 
lapses in attention are primarily responsible for between-group variation. Indeed, in a more 
recent meta-analysis of reaction time variability among children, adolescents, and adults with 
ADHD, Kofler et al. (2013) found that what accounted for group variation was SDRT, not MRT. 
Participants demonstrated significantly greater reaction time variability relative to controls, even 
after controlling for MRT.   
In sum, ADHD is a complex neurodevelopmental disorder. Accurate assessment is 
complicated by a variety of factors including symptom heterogeneity (Uno et al., 2006), 
variability in functional impairment (Spencer et al., 2007), comorbid disorders (Faraone et al., 
2000), and potentially insufficient or inadequate measures. While CPT is prevalent in ADHD 
evaluations (Munkvold, Manger, & Lundervold, 2014; Sollman et al., 2010), different versions 
have shown mixed utility in identifying ADHD and non-clinical groups, as well as differentiating 
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ADHD from other psychiatric disorders (Advokat et al., 2007; Fuermaier et al., 2018; McGee, 
Clark, & Symons, 2000; Tollander, 2011). As our understanding of ADHD genotypes, 
phenotypes, and endophenotypes evolves, we must advance our assessment tools to increase 
instrument specificity and sensitivity.   
Cognitive control deficits associated with motor response inhibition have been identified 
as a core feature of ADHD (Hart et al., 2014; McAuley et al., 2013). Specifically, stop-signal 
inhibition has been proposed as a key endophenotype (Aron & Poldrack, 2005; Schachar et al., 
2005) and research has demonstrated the clinical utility of SST in identifying ADHD and control 
groups on G/NG tasks (Alderson et al., 2007; Lijffijt et al., 2005; Oosterlaan et al., 1998). Absent 
from this literature is assessment of the diagnostic utility of stop-signal tasks in the adult 
population on tasks with greater central processing demands produced by interference control.   
The Present Study 
Research Questions 
CPT has evolved from G/NG tasks intended to measure action initiation and action 
restraint to central processing tasks involving higher cognitive demands associated with action 
cancellation and interference control. Previous research has identified MRT (i.e., inattention) as 
the primary metric that differentiates ADHD patients from non-clinical controls (Alderson et al., 
2007; Lijffijt et al., 2005). Between-group variability was attributed to inattention based on 
insignificant differences between MRT and SSRT, as well as significant differences between 
groups on SDRT. Both results suggest that an underlying factor other than inhibitory control, 
such as inattention, may account for the variability. These findings are consistent with the 
position of Castellanos and Tannock (2002) that “perhaps that most striking clinical 
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characteristics of ADHD include the transient but frequent lapses of attention, and the moment-
to-moment variability and inconsistency in performance” (p. 624).   
In contrast, when SSRT is impaired but MRT is not, the results may suggest a selective 
deficit in the action cancellation facet of motor response inhibition (Verbruggen & Logan, 2008). 
The purpose of the present study was to examine the relationships between scores on a self-
report measure of adult ADHD symptoms and CPT performance. The primary aim was to 
determine whether SSRT may predict levels of self-reported impairment from ADHD symptoms 
among adults on a CPT with greater central processing demands. This study addressed the 
following three research questions: 
1. Does SSRT, as measured by the TDIA (Long, 2018), significantly predict self-
reported symptoms of inattention, as measured by the Inattention subscale of the 
ASRS-V1.1 (Kessler et al., 2005), over and above MRT alone, as measured by the 
TDIA (Long, 2018)? 
2. Does SSRT, as measured by the TDIA (Long, 2018), significantly predict self-
reported symptoms of hyperactivity/impulsivity, as measured by the Hyperactivity-
Impulsivity subscale of the ASRS-V1.1 (Kessler et al., 2005), over and above MRT 
alone, as measured by the TDIA (Long, 2018)? 
3. Does SSRT, as measured by the TDIA (Long, 2018), significantly predict self-
reported symptoms of combined inattention and hyperactivity/impulsivity, as 
measured by the ASRS-V1.1 total score (Kessler et al., 2005), over and above MRT 
alone, as measured by the TDIA (Long, 2018)? 
Hypotheses 
In light of previous literature and based on the aforementioned research questions, the 
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following three hypotheses were established for the current study:  
 H1.  SSRT will significantly predict self-reported symptoms of inattention, over and 
above MRT alone.  
 H2.  SSRT will significantly predict self-reported symptoms of hyperactivity/impulsivity, 
over and above MRT alone. 
H3.  SSRT will significantly predict self-reported symptoms of combined inattention and 
hyperactivity/impulsivity, over and above MRT alone.  
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CHAPTER 2: METHODS 
 I designed this study to replicate and extend previous research on stop-signal tasks (SST) 
that identified stop-signal reaction time (SSRT) as the primary parameter that differentiates 
adults with ADHD from non-clinical controls (Lijffijt et al., 2005). Whereas the analysis by 
Lijffift and colleagues (2005) included only basic “Go / No-Go” tasks (G/NG), I examined the 
performances of adults on a continuous performance test (CPT) with interference control 
conditions. I also extended previous research showing that a CPT with distractor stimuli aided in 
identifying ADHD among adolescents (Berger & Cassuto, 2014), by replicating this result in an 
adult sample. While the CPT with distractors differentiated between clinical and non-clinical 
groups, the sample did not include adults and SST was not involved. Scholars have not yet 
examined the performances of adults on a CPT that includes both SST and distractor stimuli.   
In this study I examined the relationships between scores on a self-report measure of 
adult ADHD symptoms and performances on a CPT with SST and interference conditions. My 
primary aim was to preliminarily assess the clinical utility of SSRT in distinguishing between 
adults with greater self-reported ADHD symptoms and those with lesser impairment based on 
CPT performance with central processing demands. Research has shown that SSRT is useful in 
identifying individuals with self-reported, clinically significant ADHD symptoms and 
individuals with self-reported subthreshold impairment (Aron et al., 2003; Berger & Cassuto, 
2014; Kofler et al., 2013; Wodushek & Neumann, 2003).   
Research Design 
 In this study I employed a between-subjects, quantitative-descriptive, cross-sectional, 
correlational design to define and describe the nature of the relationships between two 
continuous predictor variables (i.e., MRT and SSRT) and the single continuous criterion variable 
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(i.e., self-report ratings of adult ADHD symptoms). Two measures plus a demographic 
questionnaire were administered to all participants. All participants received identical material, 
and measures were counterbalanced to account for order effects.   
Participants 
All participants were required to be, and reported being, at least 18 years of age. An a 
priori power analysis was calculated using G*Power software (Faul, Erdfelder, Buchner, & 
Lang, 2009) to estimate the necessary sample size. A hierarchical multiple linear regression was 
the primary statistical analysis selected, which included two continuous predictor variables (i.e., 
MRT and SSRT) and one continuous criterion variable (i.e., ASRS-V1.1 score). Based on an 
alpha (α) level of .05, the power analysis estimated that a minimum of 31 participants was 
necessary to obtain adequate statistical power (.80) to determine a large effect size using Cohen’s 
f2 = 0.35 standards (Cohen, 1988). At least two studies have found significant large effect sizes 
for SSRT in adult samples (Aron et al., 2003; Wodushek & Neumann, 2003). 
Sampling Procedures 
The study protocol was acknowledged by the WVU Office of Research Integrity and 
Compliance’s Institutional Review Board (IRB). Initial recruitment of undergraduate and 
graduate students at WVU was attempted using the online University Research Participation 
System, SONA, managed by the WVU Department of Psychology. SONA provides WVU 
psychology students with opportunity to participate in research to earn course credit. Alternative 
assignments are typically available for students who choose not to participate in SONA research.  
Students who register with SONA are provided a SONA ID number, which is used by SONA 
administrators to track participation. Representatives of SONA distributed information about this 
study to potentially eligible individuals within the SONA system via their webpage (see 
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Appendix A). The study’s purpose and rationale were available to potential participants 
including a detailed description of the eligibility requirements, anticipated completion time, 
participation incentive, and the researcher’s contact information. Interested and eligible 
individuals were invited to contact the researcher to obtain additional information about the 
study or to express their desire to participate. However, this recruitment strategy was 
unsuccessful in obtaining any participants. 
The recruitment letter in Appendix A was also distributed via email to graduate students 
and faculty in the Department of Counseling, Rehabilitation Counseling, and Counseling 
Psychology at WVU, as well as alumni and associates of Kalamazoo College’s and Western 
Michigan University’s Departments of Intercollegiate Athletics. The lead researcher also 
personally recruited students from the Master of Arts in Counseling program at WVU during a 
seminar on psychological assessment. 
Participants were also recruited in the MindFit Clinic (MindFit) at the WVU Carruth 
Center for Psychological and Psychiatric Services (Carruth). MindFit provides comprehensive 
psychoeducational assessment, as well as cognitive and academic enhancement services in a 
multidisciplinary program intended to improve students’ success in college. The staff is 
comprised of approximately two doctoral practicum trainees in psychology, three pre-doctoral 
psychology interns, and two licensed psychologists. All staff were trained on administration and 
data collection procedures for all measures involved in this study. Specifically, staff received 
training on procedures for recruiting participants, obtaining informed consent, maintaining 
privacy and confidentiality, securely storing participants’ data, and referring students to 
resources should they experience distress associated with participation in this study. All 
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individuals who presented for testing at MindFit and met the inclusion criterion were invited to 
participate in this study. Individuals were provided with a recruitment letter (see Appendix B).   
MindFit provides approximately 50 comprehensive Learning Disorder and ADHD 
evaluations annually. The standard battery includes a semi-structured diagnostic interview and 
measures of intellectual functioning, academic functioning, executive functioning, attentional 
processing and response control, sleep hygiene, and performance validity. Testing typically 
occurs across two, three-hour appointments on separate days. Results are integrated in a written 
report containing diagnostic impressions and treatment recommendations. Pending a request for 
further action, evaluations conclude with a review of assessment findings and the provision of a 
report to each client. Participants were informed that the measures involved in this study are not 
used in any manner nor at any time during the assessment process. Information obtained for the 
purposes of this study was not used in any manner for clinical or diagnostic purposes. 
All interested and eligible individuals were directed to a paper-form, informed consent 
document (see Appendix C) where they provided informed consent to participate. Survey 
material was identical in form across all sampling procedures. For participants associated with 
MindFit, administration of survey material occurred during either the first or second testing 
appointment at the discretion of MindFit staff; however, participants were administered only one 
CPT per appointment.  
The sampling method used in this study is called convenience sampling (Heppner, 
Wampold, & Kivlighan, 2008). Convenience sampling is a commonly used nonrandom sampling 
method wherein participants are recruited for practical reasons such as proximity, accessibility, 
and availability to the researcher (Bornstein, Jager, & Putnick, 2013; Etikan, Musa, & Alkassim, 
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2016). The use of student volunteers as research participants is a common example of 
convenience sampling (Bornstein et al., 2013).   
Measures 
World Health Organization Adult ADHD Self-Report Scale – V1.1 Symptoms Checklist 
(ASRS-V1.1) 
The World Health Organization Adult ADHD Self-Report Scale – V1.1 Symptoms 
Checklist (ASRS-V1.1; Kessler et al., 2005) is a measure of self-reported symptoms of ADHD in 
adulthood. The ASRS-V1.1 consists of 18 items that correspond to diagnostic criteria for ADHD. 
The response format involves five frequency ratings on a five-point Likert-type scale: 0 (never), 
1 (rarely), 2 (sometimes), 3 (often) and 4 (very often). None of the items are reverse scored, 
meaning that higher ratings indicate greater frequency of impairment from ADHD symptoms for 
all items. The ASRS-V1.1 total score is derived by summing points across all 18 items, with 
possible scores ranging from 0 to 72. Higher total scores indicate greater frequency of symptom 
impairment. Clinically significant symptom levels are defined as ASRS-V1.1 total score of 47 or 
greater.  ASRS-V1.1 total score of 46 or less indicate subthreshold impairment. This measure 
takes approximately 5-10 minutes to complete (Gray, Woltering, Mawjee, & Tannock, 2014).   
 The ASRS-V1.1 consists of two subscales, Inattention and Hyperactivity-Impulsivity, 
with nine items that correspond to each subscale and a range of possible scores from 0 to 36. 
Higher total subscale scores indicate greater frequency of impairment for each symptom type. 
Example items that load on the Inattention subscale include, “How often are you distracted by 
activity or noise around you?” and “How often do you make careless mistakes when you have to 
work on a boring or difficult project?” Example items from the Hyperactivity-Impulsivity 
subscale include, “How often do you leave your seat in meetings or other situations in which you 
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are expected to remain seated?” and “How often do you have difficulty waiting your turn in 
situations when turn-taking is required?” Items 1, 2, 3, 4, 7, 8, 9, 10, and 11 correspond to the 
Inattention subscale. Inattention subscale total scores of 23 or greater indicate clinically 
significant impairment. Items 5, 6, 12, 13, 14, 15, 16, 17, and 18 correspond to the 
Hyperactivity/Impulsivity subscale. Hyperactivity/Impulsivity subscale total scores of 24 or 
greater indicate clinically significant impairment. 
 The ASRS-V1.1 demonstrated adequate psychometric quality in comparison to blind 
clinical assessment of adult ADHD in a community sample of 154 individuals (Kessler et al., 
2005). Participants completed a semi-structured clinical ADHD Rating Scale (ADHD-RS; 
DuPaul, Power, Anastopoulos, & Reid, 1998), a semi-structured diagnostic interview for 
symptoms of adult ADHD, and the ASRS-V1.1. Interviews were conducted by doctoral-level 
clinical psychologists with a minimum five years of clinical experience. All 18 ASRS-V1.1 
symptom measures were significantly related to their corresponding symptom rating during 
clinical assessment. Cohen’s kappa values ranged from .16 to .81, indicating slight to substantial 
concordance across all items using standards for assessing the strength of kappa coefficients 
(Landis & Koch, 1977).  
 A second study of the ASRS-V1.1 yielded satisfactory ratings of internal consistency 
reliability (Adler et al., 2006). Responses on the self-report ASRS-V1.1 were compared to 
clinicians’ ratings on the ADHD-RS (DuPaul et al., 1998) for 60 adult patients diagnosed with 
childhood onset adult ADHD. Internal consistency was assessed using Cronbach’s alpha. The 
patient and clinician versions yielded Cronbach’s alpha coefficients of .88 and .89, respectively. 
 The ASRS-V1.1 also demonstrated sound psychometric properties in a sample of 135 
English-speaking university students with a previous ADHD diagnosis (Gray et al., 2014). 
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Responses on the self-report ASRS-V1.1 were compared to collateral reports of ADHD 
symptoms using a modified version of the ASRS-V1.1, the ASRS-V1.1 for Other developed for 
use in this study. Results indicated moderate congruence between self- and collateral-report 
versions (r = 0.46, p < 0.001). 
 As discussed above, although self-report measures can be unreliable and of questionable 
validity (Miller, Newcorn, & Halperin, 2010; Sibley et al., 2012), and vulnerable to feigned 
symptomatology (Bryant et al., 2018), self-report measures are often a core feature of adult 
ADHD evaluations (Taylor, Deb, & Unwin, 2011). Clinicians have historically used these 
measures to assess symptom presence, severity, and history (Harrison, Edwards, & Parker, 
2007).   
Test of Differential Inhibition and Attention (TDIA) 
The Test of Differential Inhibition and Attention (TDIA; Long, 2018) is a computerized, 
20-minute CPT designed to assess differential contributions of various attention networks and 
response inhibitory processes that may account for the variance in ADHD endophenotypes. CPT 
is among the most frequently employed instruments in ADHD evaluations (Munkvold et al., 
2014; Sollman et al., 2010). The TDIA combines three different cognitive tasks: a modified 
Posner cuing task (Posner, 1980) that incorporates an Eriksen Flanker design (Eriksen & 
Eriksen, 1974) and the classic stop signal paradigm (Logan, 1981; Logan & Cowan, 1984).   
The TDIA has three sequential conditions, each involving cuing (Posner, 1980) and 
flanker tasks (Eriksen & Eriksen, 1974). Participants see a series of target arrows flanked by 
other arrows and are instructed to press the left or right key that matches the direction of the 
center, target arrow. In the flanker task, subjects are presented with a target stimulus, typically an 
arrow pointing in one direction or another. Subjects are to push a button corresponding to the 
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direction of the target arrow; however, the target arrow is flanked by non-target distractors that 
point either in the same direction (in congruent trials) or the opposite direction (in incongruent 
trials) as the target. Subjects therefore must ignore the flankers, or control the interference they 
present, and maintain their attention on target stimuli. A sample is presented below. 
 
Figure 1. Congruent and incongruent trials in the Eriksen Flanker design (Eriksen & Eriksen, 
1974). 
The Posner cuing task (Posner, 1980) measures the orienting network of the human 
attentional system by presenting a visual cue prior to test stimuli. A percentage of trials has no 
visual cue preceding the target and distractor stimuli, while other trials consist of either a center 
cue, spatial cue, or invalid cue. A center cue trial involves an asterisk in the center of the 
computer screen intended to alert and orient participants that a target stimulus is upcoming; 
however, the stimulus may then appear anywhere on the screen. A spatial cue designates that the 
target and distractor stimuli appear in the same location as the preceding visual cue (i.e., top, 
center, or bottom). An invalid cue indicates that the visual cue and subsequent stimuli appear in 
different locations on the screen. The target stimulus for each trial is either congruent or 
incongruent with respect to its flanker stimuli, meaning that the target arrow points in the same 
or opposing direction as the distractor arrows, respectively.   
Condition two builds on condition one by introducing the stop-signal task (Logan, 1981; 
Logan & Cowan, 1984). In this task subjects are presented with a stop-signal (i.e., auditory tone) 
immediately following a target stimulus, typically within 50-500 milliseconds, signaling to 
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subjects to withhold a pre-trained target response. Pairing a target stimulus with a stop-signal 
increases the demand for inhibitory control (Schachar et al., 2007). On a percentage of trials, the 
tone will sound to signal that the participant should refrain from pressing either arrow keys. 
Mean values for MRT and SSRT are calculated for each respondent. MRT represents the mean 
reaction time to target stimuli across a designated number of trials and appears as “GO RT 
MEAN” in row six of the output spreadsheet. SSRT is calculated by subtracting the ending audio 
stop delay from the go reaction time (i.e., MRT – SSD) and appears in row 30 of the output. 
Finally, condition three is identical to condition two except that participants are instructed to 
ignore the stop-signal and respond to target stimuli as in condition one. Data generated in 
condition three were not included in the analysis. 
TDIA employs a tracking go-stop method whereby SSD increases by 50ms following 
successful response inhibition and decreases by 50ms following unsuccessful response 
inhibition. This method produces a desired success rate of about 50% across all trials (Alderson 
et al., 2007). After condition three, output is generated using Microsoft Excel software.   
Demographics Questionnaire 
An English version of a five-item self-report, forced-choice demographics questionnaire 
was used to collect clients’ demographic information including their age, sex, psychodiagnostic 
history of ADHD, age at time of diagnosis (if applicable), and to ascertain whether they: (1) are 
currently prescribed, (2) were previously prescribed, or (3) have never been prescribed 
psychostimulant medication. 
Procedures 
Interested and eligible individuals were recruited using the sampling procedures and 
recruitment letters described above (see Appendices A and B). Participants were required to 
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appear in-person to complete all measures. For individuals whose participation did not occur in 
conjunction with an evaluation in MindFit, 30-minute laboratory sessions were held in pre-
approved campus locations. Participants were directed to a computer where they were again 
presented with the recruitment letter (see Appendix A). As stated in Appendix A, individuals 
whose participation did not occur in conjunction with a MindFit evaluation were invited to enter 
into an anonymous, random drawing to win one of ten $10 Amazon gift cards. Interested 
participants were asked to provide their email addresses for the drawing, and they were informed 
that their addresses were not linked to their responses to maintain the anonymity of their data.   
Following review of the recruitment letter, participants were directed to an informed 
consent document (see Appendix C) where they confirmed their informed consent prior to 
accessing the measures. Responses to the demographic questionnaire and ASRS-V1.1 were 
stored in a locked filing cabinet maintained by Carruth personnel. Data from the TDIA were 
recorded and secured on an external hard drive accessible only to researchers. Participants who 
inquired about their performance on any of the measures were advised that no such information 
could be provided for the following two reasons: (1) no norms for the TDIA currently exist, and 
(2) the study is solely for experimental purposes and is not intended to be clinically informative. 
In this case, the examiner was prepared to provide participants with referrals to Carruth for a 
clinical assessment of cognitive and/or academic functioning.   
Procedures were modified for individuals whose participation occurred concurrent with a 
LD/ADHD evaluation in MindFit, in accordance with all agency policies and procedures. 
Individuals who were eligible and wished to participate in this study were presented with a 
recruitment letter (see Appendix B) and asked to provide their informed consent (see Appendix 
C) should they be eligible and wish to participate in this study. Participants were offered a $10 
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Amazon gift card in exchange for completing all measures. Responses to the demographic 
questionnaire and ASRS-V1.1 were stored in a locked filing cabinet maintained by Carruth 
personnel. Data from the TDIA were recorded and secured on an external hard drive accessible 
only to researchers.   
If a participant in MindFit inquired about their performance on any of the measures, they 
were advised that no such information can be provided for the following two reasons: (1) no 
norms for the TDIA currently exist, and (2) the study is solely for experimental purposes and is 
not intended to be clinically informative. In this case, the examiner was prepared to inform 
students that their participation in this study occurred in conjunction with a clinical assessment of 
their cognitive and/or academic functioning. Moreover, the examiner informed participants that 
their results from study materials were not to be used in any manner nor at any time to make 
clinical decisions during their formal evaluation in MindFit. 
To identify participants’ datasets and protect their privacy, each participant was assigned 
a unique code known only to their attending researcher or MindFit clinician. The coding system 
consisted of the examiner’s first and last initial followed by the numerical order in which study 
materials were administered to participants (e.g., the fifth participant of examiner “John Smith” 
would receive the following code: “JS05”). This code served as each participant’s identification 
number and was used to link demographic information to the corresponding dataset. 
Finally, all participants were thanked for their time and in cases where participants 
experienced any form or level of distress or discomfort related to study participation, they were 
referred to professional mental health services. Resources provided included the WVU Carruth 
Center for Psychological and Psychiatric Services, the WVU Quin Curtis Center and the WVU 
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Student Health Center. Participants were provided with contact information for each resource 
(see Appendix F).  
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CHAPTER 3: RESULTS 
Descriptive Statistics 
 Data were collected from 49 participants. Technological issues resulted in one 
participant’s dataset being deleted; therefore, 48 participants were included in the final sample. 
The sample consisted of four participants from the MindFit Clinic at Carruth, seven participants 
associated with Kalamazoo College and Western Michigan University, 17 participants from the 
Master of Arts in Counseling program at WVU, and 20 participants from WVU’s doctoral 
program in Counseling Psychology. 
The average age of the sample was 29.75 years, ranging from 19 to 68. Fourteen 
participants self-identified as male (29.2%), 32 self-identified as female (66.7%) and two self-
identified as non-binary (4.2%). Five participants (10.4%) had a previous diagnosis of ADHD; 
three were diagnosed between the ages of 0-12 years (6.3%), one was diagnosed between 12 and 
18 years (2.1%), and one was diagnosed at age 18 years or older (2.1%). Forty-three participants 
(89.6%) endorsed never being diagnosed with ADHD. Finally, one participant (2.1%) reported a 
current prescription for psychostimulant medication, five participants (10.4%) reported previous 
prescriptions, and 42 participants (87.5%) denied a prescription history for psychostimulants. 
Descriptive statistics for the measures are provided in Table 1.  
Table 1 
Descriptive of Measures 
 
Measure Min. Max. Mean Std. Error Std. Deviation Variance 
ASRS-V1.1 Total 9 53 26.35 1.49 10.33 106.78 
ASRS-V1.1 (I) 5 28 14.46 .77 5.37 28.93 
ASRS-V1.1 (H/I) 2 28 11.90 .89 6.18 38.22 
 TDIA MRT .56332 1.15270 .78711 .02241 .15530 .024 
 TDIA SSRT .33374 .67446 .44997 .01201 .08326 .007 
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A correlation table for the variables is presented in Table 2. The table displays a two-
tailed probability for each correlation coefficient to identify significant relationships between the 
predictor variables. As shown, there is a statistically significant correlation between the two 
predictor variables, TDIA MRT and TDIA SSRT; however, a correlation of .499 is below the 
threshold for multicollinearity (Laerd Statistics, 2015). Multicollinearity is discussed further in 
the section below on assumptions for hierarchical multiple linear regression. 
Table 2 
Correlations 
  
 ASRS-V1.1 
Total 
ASRS-V1.1 
Inattention (I) 
ASRS-V1.1 
 (H/I) 
TDIA 
MRT 
TDIA 
SSRT 
Pearson Correlation      
ASRS-V1.1 Total 1.000 .877** .908** -.274 .194 
ASRS-V1.1 (I) .877** 1.000 .596** -.207 .300* 
ASRS-V1.1 (H/I) .908** .596** 1.000 -.278 .063 
 TDIA MRT -.274 -.207 -.278 1.000 .499** 
 TDIA SSRT .194 .300* .063 .499** 1.000 
Sig. (2-tailed)      
ASRS-V1.1 Total  .000 .000 .059 .186 
ASRS-V1.1 (I) .000  .000 .157 .038 
ASRS-V1.1 (H/I) .000 .000  .056 .669 
 TDIA MRT .059 .157 .056  .000 
 TDIA SSRT .186 .038 .669 .000  
Note: *p < .05; **p < .01 
Assumptions and Reliability of the Measures 
Collected data were analyzed to ensure they met six statistical assumptions for 
hierarchical multiple linear regression: independence of observations, linearity, 
homoscedasticity, multicollinearity, outliers, and multivariate normality (Laerd Statistics, 2015). 
There was independence of residuals, as assessed by Durbin-Watson statistics of 1.656 (ASRS-
V1.1 Total), 2.154 (ASRS-V1.1 Inattention), and 2.263 (ASRS-V1.1 Hyperactivity/Impulsivity).   
The assumption of linearity is that a linear relationship exists between the criterion 
variable and both predictor variables, collectively and separately. This assumption was tested 
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using scatterplots of studentized residuals by unstandardized predicted values and partial 
regression plots, respectively. The scatterplots revealed horizontal bands indicating that the 
relationships between ASRS-V1.1 Total, ASRS-V1.1 Inattention, ASRS-V1.1 
Hyperactivity/Impulsivity, MRT, and SSRT are approximately linear. Partial regression plots 
also showed approximately linear relationships between these variables.   
Homoscedasticity assumes that the variance of error terms is similar throughout levels of 
the predictor variables. This assumption was tested through visual examination of a scatterplot of 
studentized residuals versus unstandardized predicted values to determine whether residuals are 
randomly and equally distributed across all values of predictor variables. After inspection of the 
plots, it was concluded that the assumption of homoscedasticity was not violated.   
The assumption of multicollinearity is that the two predictor variables are not highly 
correlated with each other at levels above .70 (Laerd Statistics, 2015). Inspection of correlation 
coefficients and Tolerance/Variance Inflation Factor (VIF) values revealed no multicollinearity 
problems, which arise with Tolerance values less than 0.1 and VIF values greater than 10 (Hair, 
Black, Babin, & Anderson, 2014). The Tolerance value for this sample is .751 and the VIF value 
is 1.331; therefore, it is unlikely that problems with multicollinearity would have negatively 
impacted these results. Regarding unusual data points, no outliers were identified in the casewise 
diagnostics table.   
Finally, multivariate normality assumes that the variables are normality distributed. This 
assumption was tested using a histogram and goodness-of-fit model to assess the shape of the 
distribution and identify outliers. The distribution was found to be approximately normal. 
In addition to checking assumptions for hierarchical multiple linear regression, each 
measure was assessed for internal consistency reliability. Each measure demonstrated a high 
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level of internal consistency, as determined by Cronbach’s alpha, based on interpretation 
guidelines proposed by George and Mallery (2003). The ASRS-V1.1 Total scores were found to 
have a high reliability coefficient (18 items; α = .89). Likewise, scores for the ASRS-V1.1 
Inattention subscale demonstrated high internal consistency (9 items; α = .84). Finally, the 
ASRS-V1.1 Hyperactivity/Impulsivity subscale scores also demonstrated high internal 
consistency (9 items; α = .86). The sample Cronbach’s alpha statistics are provided in Table 3. 
Table 3 
Internal Consistency Reliability of Measures 
 
Measure Items 
N 
Participants 
N 
Cronbach’s 
Alpha 
Internal 
Consistency 
ASRS-V1.1 Total 18 48 .89 Good 
ASRS-V1.1 (I) 9 48 .84 Good 
ASRS-V1.1 (H/I) 9 48 .86 Good 
 
Hypothesis Testing 
Hypothesis 1 
The first hypothesis stated that SSRT will significantly predict ASRS-V1.1 Inattention 
scores, over and above MRT alone. A hierarchical multiple regression was conducted to 
determine if the addition of SSRT improved the prediction of ASRS-V1.1 Inattention scores, 
over and above the proportion of the variance explained by MRT alone. The model included two 
continuous predictor variables (i.e., MRT and SSRT) and one continuous criterion variable (i.e., 
ASRS-V1.1 Inattention scores). The full model of MRT and SSRT was statistically significant, 
R2 = .259, F(2, 45) = 7.88, p = .001; adjusted R2 = .226.  MRT accounted for 4.3% of the 
variance in ASRS-V1.1 Inattention scores, a small effect size according to Cohen’s standards 
(Cohen, 1988). The addition of SSRT to the prediction of ASRS Inattention led to a statistically 
significant increase in R2 of .216, F(1,45) = 13.149, p = .001.  SSRT accounted for an additional 
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21.6% of the variance in ASRS-V1.1 Inattention scores, which represents a medium effect size 
(Cohen, 1988). The results of this analysis are provided in Tables 4 and 5. 
Table 4 
Model Summary 
 
Model R R Square Adjusted 
R Square 
Std. Error of 
the Estimate 
R Square 
Change 
F Change Durbin- 
Watson 
1 .207a .043 .022 5.319 .043 2.066  
2 .509b .259 .226 4.731 .216 13.149 2.154 
a. Predictors: (Constant), MRT 
b. Predictors: (Constant), MRT, SSRT 
c. Dependent Variable: ASRS-V1.1 Inattention 
 
Table 5 
ANOVA 
 
Model   Sum of Squares df Mean Square F Sig. 
 1 Regression 58.445 1 58.445 2.066 .157b 
  Residual 1301.471 46 28.293   
  Total 1359.917 47    
 2 Regression 352.740 2 176.370 7.880 .001c 
  Residual 1007.177 45 22.382   
  Total 1359.917 47    
a. Dependent Variable: ASRS-V1.1 Inattention 
b. Predictors: (Constant), MRT 
c. Predictors: (Constant), MRT, SSRT 
 
Hypothesis 2 
The second hypothesis stated that SSRT will significantly predict ASRS-V1.1 
Hyperactivity/Impulsivity scores, over and above MRT alone. A hierarchical multiple regression 
was conducted to determine if the addition of SSRT improved the prediction of ASRS 
Hyperactivity/Impulsivity, over and above the proportion of the variance explained by MRT 
alone. The model included two continuous predictor variables (i.e., MRT and SSRT) and one 
continuous criterion variable (i.e., ASRS-V1.1 Hyperactivity/Impulsivity scores). The full model 
of MRT and SSRT was statistically significant, R2 = .132, F(2, 45) = 3.41, p = .042; adjusted R2 
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= .093.  MRT accounted for 7.7% of the variance in ASRS-V1.1 Hyperactivity/Impulsivity 
scores, which is considered a small effect (Cohen, 1988). The addition of SSRT to the prediction 
of ASRS Hyperactivity/Impulsivity led to a statistically significant increase in R2 of .054, 
F(1,45) = 2.814, p = .042. SSRT accounted for an additional 5.4% of the variance in ASRS-V1.1 
Hyperactivity/Impulsivity scores, which represents a small effect size (Cohen, 1988). The results 
of this analysis are provided in Tables 6 and 7. 
Table 6 
Model Summary 
 
Model R R Square Adjusted 
R Square 
Std. Error of 
the Estimate 
R Square 
Change 
F Change Durbin- 
Watson 
1 .278a .077 .057 6.003 .077 3.853  
2 .363b .132 .093 5.888 .054 2.814 2.263 
a. Predictors: (Constant), MRT 
b. Predictors: (Constant), MRT, SSRT 
c. Dependent Variable: ASRS-V1.1 Hyperactivity/Impulsivity 
 
Table 7 
ANOVA 
 
Model   Sum of Squares df Mean Square F Sig. 
 1 Regression 138.855 1 138.855 3.853 .056b 
  Residual 1657.624 46 36.035   
  Total 1796.479 47    
 2 Regression 236.415 2 118.208 3.410 .042c 
  Residual 1560.064 45 34.668   
  Total 1796.479 47    
a. Dependent Variable: ASRS-V1.1 Hyperactivity/Impulsivity 
b. Predictors: (Constant), MRT 
c. Predictors: (Constant), MRT, SSRT 
 
Hypothesis 3 
The third hypothesis stated that SSRT will significantly predict ASRS-V1.1 Total scores 
(i.e., combined inattention and hyperactivity/impulsivity), over and above MRT alone. A 
hierarchical multiple regression was conducted to determine if the addition of SSRT improved 
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the prediction of ASRS Total, over and above the proportion of the variance explained by MRT 
alone. The model included two continuous predictor variables (i.e., MRT and SSRT) and one 
continuous criterion variable (i.e., ASRS-V1.1 Total scores). The full model of MRT and SSRT 
was statistically significant, R2 = .221, F(2, 45) = 6.376, p = .004; adjusted R2 = .186. MRT 
accounted for 7.5% of the variance in ASRS-V1.1 Total scores, which is a small effect (Cohen, 
1988). The addition of SSRT to the prediction of ASRS Total led to a statistically significant 
increase in R2 of .146, F(1,45) = 8.408, p = .004. SSRT accounted for an additional 14.6% of the 
variance in ASRS-V1.1 Total, which represents a small effect size (Cohen, 1988). The results of 
this analysis are provided in Tables 8 and 9. 
Table 8 
Model Summary 
 
Model R R Square Adjusted 
R Square 
Std. Error of 
the Estimate 
R Square 
Change 
F Change Durbin- 
Watson 
1 .274a .075 .055 10.045 .075 3.741  
2 .470b .221 .186 9.322 .146 8.4808 1.656 
a. Predictors: (Constant), MRT 
b. Predictors: (Constant), MRT, SSRT 
c. Dependent Variable: ASRS-V1.1 Total 
 
Table 9 
ANOVA 
 
Model   Sum of Squares df Mean Square F Sig. 
 1 Regression 377.472 1 377.472 3.741 .059b 
  Residual 4641.507 46 100.902   
  Total 5018.979 47    
 2 Regression 1108.215 2 554.108 6.376 .004c 
  Residual 3910.764 45 86.906   
  Total 5018.979 47    
a. Dependent Variable: ASRS-V1.1 Total 
b. Predictors: (Constant), MRT 
c. Predictors: (Constant), MRT, SSRT 
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CHAPTER 4: DISCUSSION 
Summary of Findings 
In this study I evaluated the clinical utility of stop-signal reaction time (SSRT) in the 
assessment of attentional processing and response control based on performance on a continuous 
performance test (CPT) with central processing demands in a sample of 48 adults aged 19-68 
years. The stop-signal task (SST) literature emphasizes CPT in basic “Go / No-Go” tasks (G/NG) 
formats without the additional cognitive complexity associated with interference control. 
Generally, these studies identify inattention as the predominate feature of ADHD, especially 
among children, and emphasize mean reaction time (MRT) and associated metrics as the CPT 
parameter of greatest clinical utility when differentiating ADHD and non-ADHD groups. The 
current study attempted to replicate and extend the SST literature by examining adults’ 
performances on a CPT with interference stimuli, thereby demanding greater central processing. 
A previous study of adolescents with ADHD showed that, compared to controls, the clinical 
group made significantly more omission errors in the presence of distractor stimuli than when no 
distractors were presented (Berger & Cassuto, 2014).   
The predictor variables in this study were MRT and SSRT (as measured by the TDIA).  
The criterion variable(s) was self-reported symptoms of inattention, hyperactivity-impulsivity, 
and combined (as measured by the total score and subscales of the ASRS-V1.1). MRT and SSRT 
were assessed for their respective predictive significance with three ASRS-V1.1 scales, each of 
which corresponds to one of three ADHD diagnostic classifications. Because the literature on 
SST does not always indicate which type(s) of ADHD is represented in samples, it was necessary 
to assess the predictive significance of SSRT for each ADHD subtype. Three hypotheses were 
generated to examine the relationships among these variables. 
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First, it was hypothesized that SSRT would significantly predict self-reported symptoms 
of inattention, over and above MRT alone. The analysis revealed that SSRT statistically 
significantly predicted self-reported symptoms of inattention, over and above MRT alone. The 
effect size of SSRT was medium (Cohen, 1988). Second, it was hypothesized that SSRT would 
significantly predict self-reported symptoms of hyperactivity/impulsivity, over and above MRT 
alone. The analysis revealed that SSRT statistically significantly predicted self-reported 
symptoms of hyperactivity/impulsivity, over and above MRT alone. The effect size was small 
(Cohen, 1988). Finally, it was hypothesized that SSRT would significantly predict self-reported 
combined ADHD symptoms, over and above MRT alone. The analysis revealed that SSRT 
statistically significantly predicted combined ADHD symptoms, over and above MRT alone. The 
effect size was small (Cohen, 1988). 
Overall, these results are consistent with previous research showing the predictive 
significance of SSRT in identifying ADHD and non-clinical groups of adults. Lijffijt et al. 
(2005) reported a significant difference in SSRT between adults with ADHD and matched 
controls. In their study, adult ADHD patients and controls differed significantly on SSRT, and 
not MRT, leading researchers to conclude that adult ADHD may be characterized primarily by 
deficient inhibitory control, rather than general inattention. Although the current results do not 
show that SSRT differentiates between a clinical and control group, the data suggest that SSRT 
is significantly predictive of higher or lower ratings of self-reported ADHD symptoms. The 
medium effect size for SSRT and self-reported symptoms of inattention that was obtained in this 
study is comparable to the medium effect size reported in the Lijffijt et al. (2005) study. 
The results of this analysis are consistent with a second study showing the clinical utility 
of SSRT in the adult population (Wodushek & Neumann, 2003). A significant, large main effect 
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for group (clinically significant versus subthreshold ADHD symptoms) was reported based on 
SSRT. Adults with clinically significant self-reported ADHD symptoms exhibited significantly 
slower SSRT than individuals with subthreshold symptoms. Although the current study did not 
compare between-group SSRT, self-reported ADHD symptoms were significantly predicted by 
SSRT. Larger SSRT values (i.e., slower reaction times) significantly predicted higher symptom 
ratings for inattentive, hyperactive-impulsive, and combined types of ADHD, whereas smaller 
SSRT values (i.e., faster reaction times) were related to lower symptom ratings, after controlling 
for MRT. 
Second, it was hypothesized that SSRT would significantly predict self-reported 
symptoms of hyperactivity/impulsivity, over and above MRT alone. The analysis revealed that 
SSRT statistically significantly predicted self-reported symptoms of hyperactivity/impulsivity, 
over and above MRT alone. The effect size of SSRT for hyperactivity/impulsivity symptoms was 
small (Cohen, 1988). This finding is inconsistent with research by Dinn, Robbins, and Harris 
(2001) that examined the CPT performance of 25 adults with ADHD relative to controls. Their 
results indicated that performance between groups differed only for adults with Inattentive and 
Combined ADHD, not for adults with Hyperactive-Impulsive ADHD. However, because only 
four participants in their sample were diagnosed with hyperactive/impulsive ADHD, more 
research is needed to confirm whether CPT performance may differ relative to controls for 
certain ADHD subtypes and not others. It is important to note that the measure used by Dinn et 
al. (2001) involved G/NG tasks without SST and interference conditions. Taken together, these 
results indicate that different versions of CPT may vary in the level of sensitivity to specific 
ADHD subtypes. 
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 The ability of SSRT to significantly predict self-reported hyperactive-impulsive 
symptoms among adults is noteworthy considering the common course of ADHD throughout the 
lifespan. Symptoms of hyperactivity/impulsivity are known to diminish during late adolescence 
or early adulthood for most individuals, at which point inattention often becomes preeminent 
(APA, 2013). Although adults may still experience hyperactivity or impulsivity, the degree of 
functional impairment from these symptoms may decrease due to effective selection of 
environments or compensation (Craig, 2011; Jensen et al., 1997; Lasky et al., 2016). 
Accordingly, in this sample of adults, the mean score on the ASRS-V1.1 Hyperactive-Impulsive 
subscale (11.90) was lower than the mean score on subscales for Inattention (14.46) and 
Combined symptoms (26.35).   
The composition of this sample of adults may also have contributed to the small, yet 
significant effect size of SSRT for hyperactive/impulsive symptoms. Only four participants were 
recruited in conjunction with a clinical assessment of ADHD compared to 44 participants who 
were recruited through other means. Therefore, only 0.08% of the sample represented clinical 
assessment, while 91.6% of the sample consisted of clinical analogues. Adults with hyperactive-
impulsive symptoms may have been largely underrepresented in this sample, both because of the 
reliance on analogue assessment and the relatively low prevalence of hyperactive-impulsive 
symptoms in the adult population, overall. 
 Regarding the third hypothesis, SSRT statistically significantly predicted combined 
ADHD symptoms, over and above MRT alone. This finding is consistent with previous research 
indicating slower SSRT relative to MRT in adults with ADHD combined type compared to 
controls (Aron et al., 2003; Bekker et al., 2005; Murphy, 2002). Of note, the effect size for SSRT 
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in the current study is small compared to the large effect size reported by Aron et al. (2003). This 
is perhaps due to the small sample size included in the current study. 
Overall, the results of this study contrasted with previous research on SST that identified 
inattention as the key deficit that differentiates ADHD and non-clinical groups among children 
and adolescents (Alderson et al., 2007; Oosterlaan et al., 1998). The diversity of results may be 
explained by the type of CPT represented in the analyses. Both meta-analyses examined SST 
based on G/NG performance without distractors; therefore, there may have been insufficient 
cognitive demands to illuminate inhibitory control deficits that may have otherwise existed 
between groups. A study of CPT performance with environmental distractors among adolescents 
showed that incorporating distractor stimuli aids in identifying an ADHD group (Berger & 
Cassuto, 2014). Another explanation for the discrepancy may be that the studies examined CPT 
performance among children and adolescents, whereas the current study involved an adult 
sample. A meta-analysis of adult patients showed significantly slower SSRT than MRT among 
adults, and not among children (Lijffijt et al., 2005). 
Based on the predictive significance of SSRT relative to MRT, the current results provide 
initial evidence for key inhibitory control deficits among adults with self-reported impairment 
from ADHD symptoms. This finding also provides preliminary support for an inhibition deficit 
in ADHD (Lipszyc & Schachar, 2010) and the assertion that this deficit is central to ADHD 
impairment (Barkley, 1997; Hart et al., 2014) as compared to an underlying attention deficit 
(Castellanos & Tannock, 2002). Adults with ADHD may exhibit greater deficits in action 
cancellation based on stopping latencies than action initiation when engaged in central 
processing. This research also supports the identification of response inhibition deficiency as a 
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key ADHD endopehnotype (Aron & Poldrack, 2005; McAuley et al., 2013; Schachar et al., 
2005). 
Limitations 
 While this study may meaningfully contribute to the ADHD and SST literature, it should 
be considered preliminary given that there were several limitations. First, based on the current 
results, it cannot be confirmed whether all other executive dysfunction associated with ADHD is 
secondary to deficits in response inhibition, as Barkley (1997) proposed. While the results show 
a greater deficiency in response control (i.e., action cancellation) among adults with higher 
ratings of inattentive, hyperactive-impulsive, and combined ADHD symptoms, it remains 
unknown to what extent participants’ self-reported impairment is attributable to this facet of 
executive dysfunction relative to others. Support for Barkley’s (1997) model is therefore limited 
based on the results of this study. 
Another limitation of this study is the methodology and the use of analogue assessment.  
It is unknown to what extent CPT performance exhibited in this sample represents an appropriate 
analogue of CPT performance in clinical settings. Because over 90% of participants in this 
sample did not present for clinical assessment, the extent to which these results may be 
comparable to studies that differentiate between clinical and non-clinical groups is limited. We 
are therefore unable to substantiate previous research suggesting that inhibitory control is 
significantly impaired in adults with ADHD relative to a control group (Epstein, Conners, 
Sitarenios, & Erhardt, 1998; Lijffijt et al., 2005). In the current study we did not compare mean 
SSRT scores between a clinical and control group. Rather, our purpose was to examine the 
significance of the association between SSRT scores and self-reported ADHD symptoms, after 
controlling for MRT. It remains unknown whether SSRT scores in this sample would allow for 
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differentiation between clinically significant and subthreshold impairment, which is essential for 
diagnostic purposes.  
The generalizability of these results to clinical settings may be limited due to the 
relatively low number of participants who were recruited via clinical assessment. Furthermore, 
37 of the 49 participants were graduate students, 20 of whom were doctoral students, which is an 
unlikely place to find significant signs and symptoms of ADHD given the assumed population 
prevalence. The external validity of these results is also limited because the sample was not 
randomly selected but rather was selected using convenience sampling methods. 
A third limitation of this study is the use of self-reported data to measure ADHD 
symptoms. In general, the use of self-report measures presents a limitation because it relies on 
participants’ self-report of their experience with and/or perception of the variables of interest, 
and therefore may be inaccurate (Heppner et al., 2008). Although self-report measures are often 
a core feature in ADHD evaluations (Taylor et al., 2011), research has shown that self-evaluation 
of ADHD is prone to underreporting of symptoms (Hoza et al., 2012). It cannot be determined 
whether elevations on the ASRS-V1.1 reflect true ADHD symptoms or are artifacts of other 
mental health or medical conditions. 
A fourth limitation is the potential for the results to have been influenced by different 
demand characteristics across participants in the sample. Recall that participants recruited 
through MindFit were offered a reward directly, as opposed to a random drawing for other 
participants. Participants may have responded differentially depending on which pool they were 
in, as the incentive was not the same for all participants.   
The use of an instrument that has not yet been empirically validated is another limitation 
of this study. The TDIA is a newly constructed G/NG CPT (Donders, 1969) that features three 
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cognitive tasks: a modified Posner cuing task (Posner, 1980) that incorporates an Eriksen Flanker 
design (Eriksen & Eriksen, 1974) and the classic stop signal paradigm (Logan, 1981; Logan & 
Cowan, 1984). The TDIA is an amalgamation of these well-established neuropsychological 
tasks, however the current study is the first application of the TDIA to clinical research. 
Currently there is no normative sample with which to meaningfully interpret scores. Moreover, 
the psychometric properties of the TDIA are presently unknown, thus the results of this study are 
preliminary and warrant replication in future research. Despite these limitations, the metrics with 
which the TDIA was constructed are well-supported in the literature (Alderson et al., 2007; 
Epstein et al., 2001; Lijffijt et al., 2005; Oosterlaan et al., 1998; Wodushek & Neumann, 2003).  
Implications  
Despite these limitations, the current study has several implications for assessment and 
conceptualization of adult ADHD. First, the current study provides initial evidence that 
inefficient processing due to generalized attention deficit may not be a predominate feature of 
individuals with ADHD, as has been suggested (Alderson et al., 2007; Castellanos & Tannock, 
2002; Epstein et al., 2010; Lifffijt et al., 2005; Oosterlaan et al., 1998). Research increasingly 
shows that CPT performance by adults with ADHD is distinctive from controls, with inhibitory 
control representing a key deficit in the adult clinical population (Aron et al., 2003; Bekker et al., 
2005; Lijffijt et al., 2005; Murphy, 2002; Wodushek & Neumann, 2003). Each of these studies 
show significantly slower SSRT among adult ADHD patients compared to controls. Likewise, 
the current study demonstrates that SSRT may be a useful metric in the clinical assessment of 
adult ADHD. The results are consistent with research showing that cognitive control deficits 
associated with motor response inhibition are a core feature of ADHD, with stop-signal 
inhibition being proposed as a key characteristic (Aron et al., 2003; Aron & Poldrack, 2005; 
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Berger & Cassuto, 2014; Hart et al., 2014; Kofler et al., 2013; McAuley, Crosbie, Charach, & 
Schachar, 2013; Schachar et al., 2005; Wodushek & Neumann, 2003). The current study also 
supports Barkley’s (1997) conceptual model of ADHD wherein response control deficits are 
primary to the executive dysfunction in ADHD. 
Second, because this study did not examine CPT performances among children and 
adolescents, the data do not address a myriad of studies showing inattention as a primary 
characteristic of ADHD in this population (Alderson et al., 2007; Lijffijt et al., 2005; Oosterlaan 
et al., 1998). The implication is that impairment from ADHD symptoms, as measured by CPT 
performance, may evolve from childhood to adulthood, with greater indication of attention and 
response control deficits at different points throughout the lifespan.   
Meta-analyses of SST performance among children with ADHD revealed deficits in 
response control and attention, as evidenced by significantly slower SSRT and MRT, 
respectively, compared to controls (Alderson et al., 2007; Lijffijt et al., 2005; Losier et al., 1996; 
Oosterlaan et al., 1998). A study of adults with ADHD reported similar performance profiles 
marked by greater errors of omission and commission relative to controls, suggesting deficits in 
both attention and inhibitory control (Epstein et al., 1998). However, it is important to consider 
that the studies by Losier et al. (1996) and Epstein et al. (1998) did not involve SST. It is 
possible that an alternative CPT, such as one that includes SST, may generate different results 
leading to alternate conclusions regarding the course of ADHD. Furthermore, none of the meta-
analyses included environmental distractors, thus there were no increased demands for 
interference control.   
A study by Epstein, Johnson, Varia, and Conners (2001) illustrates how the results of 
neuropsychological assessment may vary depending on the type of instrument that is employed. 
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A sample of adult ADHD patients was compared to controls on different neuropsychological 
tests, one of which was a basic G/NG task while another was a CPT with SST. On the G/NG task 
without SST, adult ADHD patients exhibited impulsive responding as evidenced by significantly 
more commission errors compared to controls. This finding suggests that adults with ADHD 
experience impairment in action restraint, specifically, due to difficulty engaging in the “no-go” 
process. Conversely, on the CPT with SST, ADHD patients and controls performed similarly, 
suggesting that differentiation of ADHD patients cannot be made based on SST performance. 
The conclusion that follows is that action cancellation is not disproportionately impaired among 
adult ADHD patients relative to controls. Moreover, it may be concluded that SST is not a useful 
metric in the clinical assessment of ADHD in adults. However, the SST task employed in this 
study did not involve interference conditions, thus relatively low cognitive processing was 
necessary for successful performance. Performance of the clinical group may differ significantly 
from controls when greater cognitive processing demands are introduced. The inclusion of 
distractor stimuli may also illuminate deficits in action cancellation among adults with ADHD, 
whereas the CPT without distractors did not.    
Third, due to diversity in measurement and methodology, the literature is mixed as to 
whether response inhibition or attention is central to ADHD dysfunction, and relatedly, which 
SST metric is most clinically useful in differentiating between ADHD and non-clinical groups. 
The current study contributes to the literature in two primary ways. It examined CPT 
performance with SST among adults, thereby measuring the action cancellation facet of motor 
response inhibition in adulthood (Schachar et al., 2007). This study also included distractor 
stimuli, thereby eliciting the need for interference control, which draws upon higher cognitive 
processing (Uno et al., 2006; van Velzen et al., 2014). Presently, no study has examined the 
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clinical utility of SST in the adult population using a CPT with environmental distractors. The 
results of this study are in contrast with the findings of Epstein et al. (2001) by showing that 
SSRT is useful in predicting self-reported ADHD symptoms, and by extension, possibly 
predicting whose symptoms may reach a diagnostic threshold versus those whose symptoms do 
not warrant clinical diagnosis. 
Finally, although CPT is commonly used in ADHD evaluations (Munkvold et al., 2014), 
numerous studies have shown questionable sensitivity and specificity for ADHD as low 
performance is characteristic of a variety of mental health disorders in addition to ADHD 
(Advokat et al., 2007; Baggio et al., 2019; Fuermaier et al., 2018; McGee et al., 2000; Tollander, 
2011). Likewise, the performance of ADHD patients may not differ significantly from controls, 
which renders the instrument minimally useful in clinical settings (Epstein et al., 2001; McGee et 
al., 2000). CPT performance is also known to be differentially useful in identifying ADHD 
patients depending on examinee age and the type of CPT (Epstein et al., 2001; Lijffijt et al., 
2005). For these reasons, advancement in clinical assessment and diagnosis of ADHD is 
contingent upon the development of tests that improve diagnostic accuracy. This study provides 
preliminary evidence for the inclusion of SST and environmental distractors in evaluations of 
adult ADHD using CPT. The results indicate that this combination of tasks yields greater 
predictive significance for identifying individuals with higher ratings of ADHD symptoms based 
on SSRT than with MRT alone. Diagnosticians may wish to consider whether a basic G/NG CPT 
without SST and environmental distractors is sufficient in identifying adult ADHD patients. 
Under these circumstances, clinicians have at their disposal only MRT, which based on the 
results of this study, has relatively low predictive power compared to SSRT. 
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Future Directions 
 Several directions for future research on SST may enhance our understanding of adult 
ADHD and advance our assessment methods to improve diagnostic accuracy in clinical settings. 
Broadly, more research is needed to clarify whether we are defining the pathology of ADHD 
correctly. This is especially necessary in light of evidence that CPT scores vary at different 
points in the lifespan (Lijffijt et al., 2005). Additionally, future research is needed to replicate 
and extend existing studies of SST, many of which show inconsistency in results. The SST 
literature will benefit from operationalization of samples and greater consistency in 
instrumentation. First, studies have shown that SSRT is useful in differentiating between ADHD 
and control groups, yet the composition of clinical groups is often unknown with regard to 
ADHD subtype. Because CPT performance may differ by ADHD subtype (Marks et al., 1999), it 
is necessary for research on SST to indicate which subtypes are included in analyses of the 
clinical utility of SST metrics. Second, Epstein et al. (2001) demonstrated that profiles of CPT 
performance may vary between clinical and non-clinical groups when different CPT versions are 
used. Conclusions regarding the utility of specific SST metrics are therefore idiosyncratic and 
limited in generalizability to all assessment settings.   
 It will also be important for researchers to continue to validate the TDIA by developing a 
normative sample of clinical and non-clinical individuals to identify clinically significant and 
subthreshold ranges of performance. This will allow for diagnostic conclusions to be drawn by 
comparing an examinee’s performance to the distribution of scores in the normative sample. The 
TDIA is presently a newly developed instrument, and this study is the first attempt at preliminary 
validation by comparing scores with an existing ADHD measure, albeit one that is self-report. 
The results of this study provide compelling evidence for further development of the TDIA for 
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assessment of ADHD in the adult population. Future research may examine the utility of the 
TDIA in predicting self-reported impairment from ADHD symptoms among children and 
adolescents.   
One area of future research is to assess the convergent validity of the TDIA and an 
existing CPT with satisfactory reliability and validity. The current study demonstrated that TDIA 
metrics are significantly correlated with three scales from an existing self-report measure of adult 
ADHD symptoms, the ASRS-V1.1 (Kessler et al., 2005). Due to the limitations associated with 
self-report measures, it befits TDIA developers to assess the TDIA’s validity in comparison with 
a more objective measure of ADHD symptoms, such as the IVA+Plus (Sandford & Turner, 
2004). This research would allow for comparison of the TDIA and a CPT with a G/NG format, 
which would be useful in replicating the Epstein et al. (2001) results that showed that ADHD and 
control groups perform differentially on CPT with and without SST. Furthermore, it will be 
important for researchers to assess the clinical utility of the TDIA in comparison with other 
CPTs that involve SST, such as the Stop-Signal task (Logan, 1994), which was employed by 
Wodushek and Neumann (2003) in their assessment of adult ADHD. Replication and extension 
of this study will be necessary to demonstrate that SSRT is slower for adults with ADHD 
compared to controls, and to highlight response inhibitory deficits in adults with ADHD based 
on stopping latencies. Finally, the TDIA is the only known CPT that includes SST and a Flanker 
task (Eriksen & Eriksen, 1974) to measure SSRT amid greater inhibitory control demands 
generated by environmental distractors. Research and development of the TDIA will necessitate 
that the test be validated alongside similar instruments, should such measures be introduced. 
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Conclusion 
ADHD is among the most common mental health disorders in adults (APA, 2013). The 
goal of the current study was to advance the stop-signal task literature by examining the 
relationships between mean reaction time, stop-signal reaction time, and three scales pertaining 
to self-reported ADHD symptoms. Examining the predictive significance of these variables 
contributed to the SST literature by highlighting the diagnostic utility of SSRT in an adult 
sample of clinical analogues and by analyzing a CPT that includes SST and environmental 
distractors. It was hypothesized that SSRT would significantly predict self-reported ADHD 
symptoms, after statistically controlling for MRT. The results supported this hypothesis for 
symptoms of inattention , hyperactivity/impulsivity, and combined symptoms. Future research 
examining the clinical utility of SST with more complex CPT methodology may improve clinical 
assessment and advance our understanding of ADHD in the adult population.    
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APPENDICES 
Appendix A: Informational Cover Letter – Form A 
Dear Participant, 
 
My name is Ben Darling and I am a doctoral candidate in Counseling Psychology at West 
Virginia University (WVU).  I kindly request your participation in a research study titled: 
“Associations between the Adult ADHD Self-Report Rating Scale and the Test of Differential 
Inhibition and Attention.”  The primary aim of this study is to assess the validity of a newly 
developed measure of attentional processing and response control in adulthood.  The study 
involves completing a basic demographics questionnaire, one self-report survey of attention and 
hyperactivity/impulsivity, and one computerized continuous performance test. 
 
This project has been acknowledged by the Institutional Review Board at WVU and is being 
conducted under the guidance of Dr. Monica Leppma, Associate Professor.  Your participation is 
completely voluntary and you may withdraw from the study at any time without penalty.  Your 
involvement will be kept as confidential as legally possible and no identifying information will 
be collected.  You will have the option of providing your email address to enter an anonymous, 
random drawing to win one of ten $10 Amazon gift cards. This information will be kept separate 
from your individual responses to the survey questions. 
 
Your participation in this study is highly valued and will require no more than 35 minutes of 
your time.  This study will be conducted on WVU’s Evansdale Campus at a designated time and 
location. Please send an email to abdarling@mix.wvu.edu for more information on how to 
participate in this study. 
 
Thank you for your consideration.  Please do not hesitate to contact Ben Darling 
(abdarling@mix.wvu.edu) or Dr. Monica Leppma (monica.leppma@mail.wvu.edu) should you 
have questions or need additional information. 
 
Sincerely, 
 
Ben Darling, M.A. 
Counseling Psychology Doctoral Candidate 
Department of Counseling, Rehabilitation 
Counseling, and Counseling Psychology 
West Virginia University | Morgantown, WV 
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Appendix B: Informational Cover Letter – Form B 
Dear Participant, 
 
My name is Ben Darling and I am a doctoral candidate in Counseling Psychology at West 
Virginia University (WVU).  I kindly request your participation in a research study titled: 
“Associations between the Adult ADHD Self-Report Rating Scale and the Test of Differential 
Inhibition and Attention.”  The primary aim of this study is to assess the validity of a newly 
developed measure of attentional processing and response control in adulthood.  The study 
involves completing a basic demographics questionnaire, one self-report survey of attention and 
hyperactivity/impulsivity, and one computerized continuous performance test. 
 
This project has been acknowledged by the Institutional Review Board at WVU and is being 
conducted under the guidance of Dr. Monica Leppma, Associate Professor.  Your participation is 
completely voluntary and you may withdraw from the study at any time without penalty.  Your 
involvement will be kept as confidential as legally possible and no identifying information will 
be collected.  
 
Your participation in this study is highly valued and will require no more than 35 minutes of 
your time.  As a thank you, you will be provided with one $10 Amazon gift card for participating 
in this study. This study will be conducted in the MindFit Clinic at the WVU Carruth Center for 
Psychological and Psychiatric Services (MindFit) by trained personnel.  Please contact your 
MindFit representative if you have questions or need additional information about this study. 
 
Thank you for your consideration.  Please do not hesitate to contact Ben Darling 
(abdarling@mix.wvu.edu) or Dr. Monica Leppma (monica.leppma@mail.wvu.edu) should you 
have questions or need additional information. 
 
Sincerely, 
 
Ben Darling, M.A. 
Counseling Psychology Doctoral Candidate 
Department of Counseling, Rehabilitation 
Counseling, and Counseling Psychology 
West Virginia University | Morgantown, WV 
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Appendix C: Informed Consent 
Only Minimal Risk 
Consent Information Form 
(without HIPAA) 
Principal Investigator  Monica 
Leppma, Ph.D. 
Department   Counseling, Rehabilitation Counseling, and Counseling Psychology 
Protocol Number  1901443696 
Study Title   Associations between the Adult ADHD Self-Report Rating Scale (ASRS) and 
the Test of Differential Inhibition and Attention (TDIA) 
Co-Investigator(s)  Ben Darling, M.A. 
Sponsor (if any)  N/A 
 
Contact Persons 
 
In the event you experience any side effects or injury related to this research, you should contact the Carruth 
Center for Psychological and Psychiatric Services at (304) 293-4431. If you have any questions, concerns, or 
complaints about this research, you can contact Dr. Monica Leppma at (304) 293-0540. 
 
For information regarding your rights as a research subject, to discuss problems, concerns, or suggestions 
related to the research, to obtain information or offer input about the research, contact the Office of Research 
Integrity and Compliance at (304) 293-7073. 
Introduction 
You, _______________, have been asked to participate in this research study, which has been explained to you 
by _______________. This study is being conducted by Ben Darling, M.A. and Monica Leppma, Ph.D., in the 
Department of Counseling, Rehabilitation Counseling, and Counseling Psychology at West Virginia University. 
Purpose(s) of the Study 
The purpose of this study is to examine the relationship between scores on a self-report measure of adult ADHD 
symptomatology and CPT performance to aid in the validation of a newly developed computerized assessment 
of ADHD symptoms.  The primary aim is to determine whether SSRT may distinguish between individuals 
with self-reported impairment from ADHD symptoms and those who report no such impairment on a CPT with 
greater central processing demands.   
Description of Procedures 
This study involves analysis of self-report and objective measures of attentional processing and response 
control. Participation in this study will take approximately 30 minutes. You do not have to answer every 
question. You are being invited to allow your anonymous scores to be included in the analyses. 
Discomforts 
There are no known or expected risks from participating in this study, except for the mild frustration associated 
with answering the questions. Should you experience any form or degree of distress related to your participation 
in this study, resources are available at the WVU Carruth Center for Psychological and Psychiatric Services 
(304-293-4431), WVU Quin Curtis Center (304-293-1824), and WVU Student Health Center (855-WVU-
CARE). 
Alternatives 
You do not have to participate in this study. 
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Benefits 
You may not receive any direct benefit from this study. The knowledge gained from this study may eventually 
benefit others. 
Financial Considerations 
There are no special fees for participating in this study.  
Confidentiality 
Any information about you that is obtained through your participation in this research will be kept as 
confidential as legally possible. Your research records and test results, just like hospital records, may be 
subpoenaed by court order or may be inspected by the study sponsor or federal regulatory authorities (including 
the FDA if applicable) without your additional consent. 
 
In any publications that result from this research, neither your name nor any information from which you might 
be identified will be published without your consent. 
Voluntary Participation 
Participation in this study is voluntary.  You are free to withdraw your consent to participate in this study at any 
time. 
 
Refusal to participate or withdrawal will not affect your class standing or grades, as appropriate, and will 
involve no penalty to you. Refusal to participate or withdrawal will not affect your future care, or your 
employee status, as appropriate, at West Virginia University. 
In the event new information becomes available that may affect your willingness to participate in this 
study, this information will be given to you so that you can make an informed decision about whether or 
not to continue your participation. 
 
You have been given the opportunity to ask questions about the research, and you have received answers 
concerning areas you did not understand. 
 
Upon signing this form, you will receive a copy. 
 
I willingly consent to participate in this research. 
 
 
 
______________________________________________________________________________ 
Printed Name                                Signature                                           Date                           Time 
 
 
The participant has had the opportunity to have questions addressed.  The participant willingly 
agrees to be in the study. 
 
Signature of Investigator or Co-Investigator 
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_________________________________________________________________      __________   
Printed Name                           Signature                                                Date                           Time              
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Appendix D: Demographics Questionnaire 
Please complete the following information. 
Item Text Answers Type 
1 Age: _______ Text 
Entry 
2 Sex: o Male 
o Female 
o Self-Identify: _______ 
Multiple 
Choice 
3 Have you ever been clinically diagnosed 
with Attention-Deficit Hyperactivity 
Disorder?  
o Yes 
o No 
Multiple 
Choice 
4 If you answered “Yes” on Item 3, how 
old were you (in years) when you were 
diagnosed? If you answered “No” on 
Item 3, proceed to Item 5. 
o Between 0 and 12 
years 
o Between 12 and 18 
years 
o 18 or older 
Multiple 
Choice 
5 Which of the following best describes 
you? 
o Currently prescribed 
psychostimulant 
medication 
o Previously prescribed 
psychostimulant 
medication, but not 
currently 
o Never prescribed 
psychostimulant 
medication 
Multiple 
Choice 
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Appendix E: Adult ADHD Self-Report Scale (ASRS-V1.1) Symptom Checklist 
 
Please answer the questions below, rating yourself on each of the criteria shown using the scale 
provided.  Please select the answer that best describes how you have felt and conducted yourself 
over the past 6 months. 
 
1. How often do you have trouble wrapping up the final details of a project, once the challenging 
parts have been done? 
Never Rarely Sometimes Often Very Often 
0 1 2 3 4 
 
2. How often do you have difficulty getting things in order when you have to do a task that requires 
organization? 
Never Rarely Sometimes Often Very Often 
0 1 2 3 4 
 
3. How often do you have problems remembering appointments or obligations? 
Never Rarely Sometimes Often Very Often 
0 1 2 3 4 
 
4. When you have a task that requires a lot of thought, how often do you avoid or delay getting 
started? 
Never Rarely Sometimes Often Very Often 
0 1 2 3 4 
 
5. How often do you fidget or squirm with your hands or feet when you have to sit down for a long 
time? 
Never Rarely Sometimes Often Very Often 
0 1 2 3 4 
 
6. How often do you feel overly active and compelled to do things, like you were driven by a 
motor? 
Never Rarely Sometimes Often Very Often 
0 1 2 3 4 
 
7. How often do you make careless mistakes when you have to work on a boring or difficult 
project? 
Never Rarely Sometimes Often Very Often 
0 1 2 3 4 
 
8. How often do you have difficulty keeping your attention when you are doing boring repetitive 
work? 
Never Rarely Sometimes Often Very Often 
0 1 2 3 4 
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9. How often do you have difficulty concetrating on what people say to you, even when they are 
speaking to you directly? 
Never Rarely Sometimes Often Very Often 
0 1 2 3 4 
 
10. How often do you misplace or have difficulty finding things at home or at work? 
Never Rarely Sometimes Often Very Often 
0 1 2 3 4 
 
11. How often are you distracted by activity or noise around you? 
Never Rarely Sometimes Often Very Often 
0 1 2 3 4 
 
12. How often do you leave your seat in meetings or other situations in which you are expected to 
remain seated? 
Never Rarely Sometimes Often Very Often 
0 1 2 3 4 
 
13. How often do you feel restless or fidgety? 
Never Rarely Sometimes Often Very Often 
0 1 2 3 4 
 
14. How often do you have difficulty unwinding and relaxing when you have time to yourself? 
Never Rarely Sometimes Often Very Often 
0 1 2 3 4 
 
15. How often do you find yourself talking too much when you are in social situations? 
Never Rarely Sometimes Often Very Often 
0 1 2 3 4 
 
16. When you’re in conversation, how often do you find yourself finishing the sentences of the 
people you’re talking to, before they can finish them themselves? 
Never Rarely Sometimes Often Very Often 
0 1 2 3 4 
 
17. How often do you have difficulty waiting your turn in situations when turn-taking is required? 
Never Rarely Sometimes Often Very Often 
0 1 2 3 4 
 
18. How often do you interrupt others when they are busy?   
Never Rarely Sometimes Often Very Often 
0 1 2 3 4 
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Appendix F: Closing Statement and Resources 
 
Thank you for your participation! 
 
If you are currently experiencing any form or level of distress, and wish to seek professional 
assistance, mental health services are available at the following locations: 
 
Carruth Center for Psychological and Psychiatric Services | West Virginia University 
http://well.wvu.edu/ccpps  
(304)293-4431 
 
Quin Curtis Center | West Virginia University 
https://psychology.wvu.edu/about/quin-curtis-center 
(304) 293-1824 
 
Student Health Center | West Virginia University 
https://wvumedicine.org/ruby-memorial-hospital/services/wvu-specialty-clinics/student-health/ 
(855) WVU-CARE 
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Appendix G: IRB Acknowledgement of Exemption 
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